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Abstract 
Kudingcha is an herbal tea which is widely consumed in southern China. It is 
used as a folk medicine, a stimulant to the central nervous system, a diuretic, a 
treatment for sore throat, and an aid for losing weight and for the relief of 
hypertension. Kudingcha is a generic name referring to several families and species. 
In the present study, Ligustrum purpurascens which belongs to the family of 
Oleaceae was used. Five phenylethanoid glycosides, including acteoside, 
ligupurpuroside A, c/5-ligupurpur0side B, ^raw5-ligupurpuroside B and osmanthuside 
B were isolated and purified. Isoacteoside was formed when acteoside was heated at 
100 °C. The present study was to mainly examine the antioxidative activity of these 
phenylethanoid glycosides. 
Acteoside, isoacteoside and ligupurpuroside A demonstrated strong antioxidative 
activity in Cu2+-mediated oxidation of human low-density lipoprotein (LDL) in vitro 
while cw-ligupurpuroside B, ^raw5-ligupurpuroside B and osmanthuside B showed 
little or no protection on human LDL. The inhibitory effects of acteoside, isoacteoside 
and ligupurpuroside A were dose-dependent at concentrations ranging from 5 to 40 
^M. The phenylethanoid glycosides extracted from Kudingcha did not show any 
chelating effect on Cu^ + ion to inhibit the initiation of free radicals. The results 
suggest that part of the mechanism by which these phenylethanoid glycosides 
function as antioxidants is due to their free radical scavenging capacity but it is 
unlikely mediated by their chelation to heavy metal ions. 
Acteoside, isoacteoside and ligupurpuroside A not only inhibited LDL oxidation 
but also prevented a-tocopherol from depletion in human LDL in vitro. Acteoside, 
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isoacteoside and ligupurpuroside A showed dose-dependent protective effects on a-
tocopherol at concentrations ranging from 1 to 10 i^M. cw-Ligupurpuroside B, trans-
ligupurpuroside B and osmanthuside B showed little or no inhibitory effects on a-
tocopherol consumption in human LDL. Acteoside was also shown to be capable of 
regenerating a-tocopherol from its free radical form. 
Kudingcha extract relaxed the U46619-preconstricted rat isolated aortic rings in 
a concentration-dependent manner. The extract also reduced the contraction induced 
by 35 mM K+ or by 1 i^M phorbol 12,13-diacetate (PDA) in endothelium-intact rings. 
The extract (0.10-0.30 mg/ml) reduced the concentration-response to U46619 in 
normal Krebs solution or CaCl2 in 35 mM K+-containing solution. Acteoside induced 
a concentration-dependent relaxation of rings preconstricted by U46619 but it caused 
a further increase in 35 mM K+-induced tone. Removal of the functional endothelium 
enhanced the relaxing effect of acteoside. Besides, pretreatment with acteoside 
inhibited endothelium/nitric oxide-mediated relaxation induced by acetylcholine. 
Acteoside (0.125-0.250 mg/ml) also enhanced the contractile response to CaCl2 in 35 
mM K+, Ca2+-free Krebs solution. 
By using New Zealand White rabbit as an animal model, the effect ofKudingcha 
on serum lipid contents of rabbit was examined. Rabbits were fed with 1% cholesterol 
added synthetic diet with or without 3% Kudingcha as drinking fluid throughout 12 
weeks. There were no differences in serum total triacylglycerols (TG), total 
cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), hepatic cholesterol 
and percentage of atheroma formation in aorta. In another animal study in which 
golden Syrian hamsters were used. Similar results were demonstrated when animals 
were fed with a high-fat and high-cholesterol semi-synthetic diet with or without 3% 
water extract of Kudingcha or 0.94% ethanol extract of Kudingcha. After 4 weeks, no 
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differences were found in serum TG, TC, HDL-C and hepatic cholesterol. 
In conclusion, the present data suggest that Kudingcha {Ligustrum purpurascens) 
contains active antioxidants. These phenylethanoid glycosides may act as protective 
agents to human LDL from free radical attack either directly or via the mechanism of 
maintaining or regenerating a-tocopherol. In addition, Kudingcha extract and pure 
acteoside exhibited a relaxing activity in rat aortic rings, suggesting that they may 
have anti-hypertensive effect. The rabbit and hamster studies did not support the view 
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1.1 History of Kudingcha 
Tea has an ancient history. A Chinese legend teacher that in the year 2737 BC 
the Emperor Shen Nung discovered tea drinking while on an outing to the countryside 
(Balentine, 1992). In 350 AD, the first handbook about the use and horticulture oftea, 
Ch'a Ching, was written by a Chinese scholar，Kou P'o. (Balentine, 1992). 
Kudingcha is also widely used as a traditional beverage in southern China. The 
first handbook about the use of Kudingcha was Ben Jing Feng Yuan. The 
Compendium ofMateria Medica also stated the use and function of Kudingcha. In 
general, Kudingcha is used in folk medicine in China as diuretic and for the treatment 
of sore throat, weight loss and hypertension. But there have been no solid scientific 
data to prove the activity ofKudingcha. 
1.2 Classification of Kudingcha 
Kudingcha is a generic name, which refers to different families and species. 
There are altogether 10 different species belonging to 5 different families called 
"Kudingcha". These families include Oleaceae, Aquifoliaceae, Guttifera, Ehretiaceae 
and Rosaceae (Table 1.1). All Kudingchas are found in southern China, mostly in 
Guangxi, Guizhou, Zhejiang, Yunnan and Sichuan. Different natural pure compounds 
have been isolated from different species of Kudingcha. Triterpenoid saponins and 
triterpenoid glycosides are usually found in the Kudingcha belongs to the family of 
Aquifoliaceae, i.e. Ilex cornuta, Ilex kudingcha and Ilex latifolia fNishimura et al., 
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Table 1.1 Classification ofKudingcha 
Latin name Family name Place 
Ligustrum pedunculare Oleaceae Sichuan 
Rehd. 
Ligusrum purpurascens Oleaceae Yunnan 
Y. C. Yang 
Ligustrum japonicum var. pubescens Oleaceae Guizhou 
Koidz 
Ligustrum. robstum Oleaceae Guizhou 
(Roxb.) B1. 
Ilex cornuta Aquifoliaceae Zhejiang 
Lindl. Ex Paxt. 
Ilex kudingcha Aquifoliaceae Guangxi 
C. J. Tseng — 
Ilex latifolia Aquifoliaceae Zhejiang, Hunan 
Thunb. 
Cratoxylum prunifolium Gultifera Guangxi 
(Kurz) Dyer 
Ehretia thysiflora Ehretiaceae Guangxi 
(S. et Z.) Nakai 
Potinia serruiata Rosaceae Zhejiang ] ^ 
(Adapted from He et al., 1992) 
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1999，Ouyang et al； 1996a，1996b，1997). In the family of Oleaceae Kudingcha, i.e. 
Ligustrum purpurascens and Ligustrum japonicum, phenylethanoid glycosides are 
usually found (Jimenez et aL, 1994，He et al； 1992) 
In the present study, Ligustrum purpurascens from the family of Oleaceas was 
chosen. Ligustrum purpurascens was found in Zhaotong, Yunnan Province, China. 
Zhaotong belongs to the sub-tropical area which is suitable for Ligustrum 
purpurascens to grow. Drinking Kudingcha (Ligustrum purpurascens) is very popular 
in Yunnan. Kudingcha becomes the commercial drink in that region. The species of 
this plant was identified by Professor P. Y. Bai at Kunming Institute of Botany, 
Academia Sinica. The voucher specimen is deposited in the Herbarium of Kunming 
Institute ofBotany，Yunnan, China. 
1.3 Composition ofLigustrum purpurascens 
The chemical composition ofKudingcha (Ligustrum purpurascens) has not been 
fully characterized. To my best knowledge, seven natural products have been 
identified in Ligustrum purpurascens. They are four phenylethanoid glycosides, i.e., 
acteoside, osmanthuside B，ligupurpuroside A and ^raw5-ligpurpuroside B and three 
flavonoids, i.e. luteolin-7-glucoside, cosmosiin and rhoifolin (He et aL, 1992). In the 
genus of Ligustrum, it is found that caffeine, tannin, triterpenoid saponins and 
triterpenoid glycosides were absent. But triterpenoid saponins and triterpenoid 
glycosides are found in the Kudingcha belonging to the family of Aquifoliaceae 
OvJishimura et al., 1999, Ouyang et al., 1996a，1996b，1997). In the present study, the 
biological activities of the phenylethanoid glycosides isolated from Ligustrum 
purpurascens were examined. 
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1.4 Introduction to phenylethanoid glycosides 
Phenylethanoid glycosides (PhGs) are a group of water soluble natural 
compounds widely distributed in the plant kingdom, most of which are isolated from 
medicinal plants. Structurally, they are characterized by having cinnamic acid and 
hydroxyphenylethyl moieties attached to a P-glucopyranose through ester and 
glycosidic linkages respectively. Rhamnose, xylose, apiose, etc. may also be attached 
to the glucose residue, which forms the core of the molecule in most cases. 
There is much confusion in the literature regarding the names and structures of 
these metabolites and this represents additional complication for those interested in 
these compounds. The first literature references to phenylethanoid glycosides 
concerned the isolation of echinacoside from Echinacea angustifolia (Asteraceae) 
by Stroll et al. (1950) and verbascoside from Verbascum sinatum (Scrophulariaceae), 
but their structures were not determined at that time. Verbascoside was isolated again 
in 1966 from Syringa vulgaris (Oleaceae) (Birkofer et al., 1968), but it was named as 
acteoside. In 1982 Andary et aL (1982) found that the structures of verbascoside and 
acteoside were identical. One year later, kusaginin was isolated from Clerodendron 
tricholomum (Verenaceae) (Sakurai and Kato, 1983) and subsequently shown to be 
identical to verbascoside (acteoside). Acteoside is now the accepted name for this 
natural compound. 
1.4.1 Isolation and purification ofphenylethanoid glycosides 
Phenylethanoid glycosides are not specific to any plant organ, having been 
isolated from plant roots, bark, leaf aerial parts, etc., and also from callus tissue and 
suspension cultures. Extraction of PhGs from the plant is usually achieved by polar 
organic solvents (methanol, and to lesser extent, ethanol and ethyl acetate). The use of 
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silica gel and chloroform-methanol or chloroform-methanol-water as eluent is very 
common (Sugiyama and Kikuchi, 1990). Gentle chromatographic methods (Sephadex 
LD-20，polyamide, cellulose, or Diaion HP-20) are also recommended. 
1.4.2 Taxonomy of phenylethanoid glycosides 
PhGs are widely distributed in plants. The most widely studied families are 
Scrophulariaceae (35 species), Oleaceae (25 species), Plantaginaceae (25 species), 
Lamiaceae (15 species) and Orobanchaceae (14 species) (Jimenez and Riguera, 
1994). 
PhGs isolated from each species vary widely. Rehmannia glutinosa var. 
purpurea (Scrophulariaceae) is a richest source, with 20 glycosides so far being 
reported, followed by Plantago asiatica (Plantaginaceae), Cistanche salsa and 
Cistanche tubulosa (Orobanchaceae) with 15, 14 and 11 glycosides being isolated, 
respectively. 
Although the chemotaxonomic aspects of PhGs are far from being fully 
established, studies involving their use as taxonomic markers have been undertaken. 
The phenylethanoid glycosides studied include poliumoside, which seems to be 
typical ofthe polium species ofthe Labiatae genus Teucrium, as well as the glycoside 
esters of Syringa and Digitalis spp. An interesting study on the use of acteoside and 
purpureaside A (plantamajoside) as valuable taxonomic markers in Plantago species 
(Plantaginaceae) has also been described. 
1.4.3 Structure ofphenylethanoid glycosides 
The phenylethanoid glucosides reported in the literature can be classified 
according to the number and type of sugars. The two basic units of the phenylethanoid 
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glucosides are the glucose and the phenylethanoid moieties (Figure 1.1). Mostly, 
either hydroxyl group or hydrogen attaches to the R5 or R6 position of the 
phenylethanoid glycosides. Aromatic groups, i.e., caffeoyl, cinnamoyl, coumaroyl, 
feruloyl, usually attach to the R2, R3 or Reposition of the phenylethanoid glycosides. 
Phenylethanoid glycosides can be divided into monosaccharides, disaccharides and 
trisaccharides. For the monosaccharides, the RJ group is hydrogen substitute. And all 
of them are glucopyranosides, with caffeic and gallic acids being the most common 
aromatic groups bonded to the glucose. Sometimes, p-hydroxyquinone and the 
reduced form of the hydroxyphenylethyl aglycone bond to the glucose of the 
monosaccharide phenylethanoid glucosides. Rhamnose usually attaches to C-3' (Ri) 
of glucose for the disaccharide phenylethanoid glucosides. The trisaccharides are the 
most common PhGs. They all contain rhamose as the second sugar unit in Ri position. 
The trisaccharides have been distributed into two sub-groups according to the point of 
attachment ofthe second sugar. One group is that the second sugar attaches to the C-
3’（Ri) ofthe glucose and the second sugar attaches to the C-6, (R )^ ofthe glucose. 
The third sugar unit may be glucose, xylose, arabinose, apiose, galactose, lyxose or 
rhamnose which attaches to the second sugar unit. Caffeic, ferulic, and cirmamic acids 
are the most common aromatic acids, usually linked to C-4' (R2) of the glucose, 
although others such as gallic and vanillic acid also occur. 
1.4.4 Biosynthesis ofphenylethanoid glycosides 
Phenylethanoid moiety is derived from the amino acid phenylalanine or cinnamic 
acid whereas the hydroxyphenylethanol portion is from tyrosine or tyramine (Figure 
1.2). Phenylalanine and tyrosine are synthesized from chorismate in plants and 
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The paths branch at prephenate, and the final step in both cases is transamination with 
glutamate as amino group donor. In dicots, phenylalanine ammonia lyase catalyzes 
the anti-elimination of ammonia from phenylalaine to give cinnamic acid, it does not 
use tyrosine as a substrate. Microsomal cytochrome P-450 dependent monooxygeases 
have been reported to catalyze formation of the various cinnamic-acid derivatives 
containing phenolic or catecholic functionalities. For instance, monooxygenase and 
cinnamate-4-hydroxylase catalyze the conversion of cinnamic acid into coumaric acid. 
And phenolase catalyzes caffeic acid formation. Then 0-methyltransferases catalyze 
the methylation of caffeic acid at position 3. Hydroxycinnaml CoA ligase catalyzes 
the transformation of cinnamic acids into phenylethanoid metabolites. 
Biosynthetic studies of acteosie and salidroside by linear-phase suspension 
cultures of Syringa vularis (Oleaceae) using radioactive precursors have shown that 
the phenylethanoid moiety is derived from the amino acid phenylalanine or cinnamic 
acid, while the hydroxyphenylethanol portion is from tyrosine or tyramine (Ellis, 
1983). A second study revealed that dihydroxy precursors such as L-DOPA and 
dopamine were less efficiently incorporated into acteoside than their monohydroxy 
equivalents (Ellis., 1983). 
1.4.5 Pharmacological effects ofphenylethanoid glycosides 
Phenylethanoid glycosides are only discovered in last 40 years and are abundant 
in plant kingdom. In recent years, phenylethanoid glycosides have attracted much 
attention in relation to their physiological and biological properties, such as 
anticarcinogenic, antioxidative, immunosuppressive, hepatoprotective, antibacterial, 
antiviral, antiinflammatory, antinociceptive, DNA-repairing activity and inhibitory 
activity to PKC-a. 
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1,4.5,1 Anticarcinogenic activity 
Several studies have examined the effect of phenylpropanoid glycoside on cancer 
cells. Acteoside, one ofthe phenylpropanoid glycoside, isolated from the aerial parts 
of Phlomis armeniaca Willd, Scutellaria salviifolia Bentham induced cell death in 
promyelocytic leukemia HL-60 cells. Acteoside induced the intemucleosomal 
breakdown of chromatin DNA characteristic of apoptosis (Inoue et aL, 1998a). When 
human gastric adenocarcinoma MGc80-3 cells were treated with acteoside isolated 
from Pedicularis strita Pall (Jueyehesen), the growth curve and mitotic index 
decreased remarkably (Li et al., 1997b). Acteoside isolated from Scutellaria salvifolia 
Bentham (Lamiaceae) was found to induce interleukin (IL)-1, and tumor necrosis 
factor-a (TNF-a) in macrophage-like cell line J774.A1 (Inoue et al., 1998b). 
Acteoside, forsythoside B，phlinoside B isolated from Phlomis armeniaca , and 
teucriosde isolated from Scutellaria salviifolia showed cytotoxic activity against rat 
hepatoma dRLh-84 cells and mouse sarcoma S-180 cells (Saracoglu et al., 1995). 
1,4.5,2 Inhibitory activity of protein kinase C 
Ca2+/phospholipid-dependent protein kinase, protein kinase C (PKC), plays a 
crucial role in signal transduction, cellular proliferation, and differentiation, but the 
pleiotropic effects ofthis enzyme in cellular regulation and its involvement in tumor 
promotion underscore the importance of understanding its mechanism of regulation. 
Inhibition on PKC is one of the important steps in tumor controlling process. 
Acteoside isolated from Lantana camara L. (Verbenaceae) is an inhibitor of PKC 
from the rat brain. It interacted with the catalytic domain of PKC (Herbert et aL, 
1991). Calceolarioside A, calceolarioside B, forsythiaside and plantainoside D from 
Digitalispurpurea, and leucosceptoside A, poliumoside, acteoside and pantarenalosie 
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from Penstemon linarioides all showed PKC-inhibitory bioactivity (Zhou et aL, 
1998). 
1,4.5.3 Immunosuppressive activity 
Separation of the immunosuppressive components from Rehmanniaw radix was 
done by monitoring hemolytic plaque-forming cells (HPFC) inhibitory activity. 
Actesoide, isoacteoside, jionosides A ,^ jionosides B ,^ purpureaside C, echinacoside 
and cistanosides A and F isolated from Rehmannia glutinosa var. hueichingensis 
showed the immunosuppressive activity (Hiroshi et al., 1988). 
L4,5,4DNA repairing activity 
DNA damage is involved in many pathologic processes, including reproductive 
cell death, mutagenesis and transformation. DNA damage can be caused by the 
environmental agents, such as ionizing radiation, UV light and a variety of chemicals 
as well as normal metabolism in which reactive oxygen species are formed as side-
products. Acteoside, pedicularioside A and cistanoside C isolated from Pedicularis 
species are demonstrated to enhance the repair reaction 2 ‘ -deoxyadenosine-5 ‘-
monophosphate (Damp) radical anions, thereby protecting DNA from hydrated 
electron attack (Shi et al., 2000). Therefore, phenylpropanoid glycosides may act as a 
series ofefficient radioprotectors and therapeutical agents for the diseases related with 
DNA damage. 
L4,5.5Antibacterial and antiviral activities 
Luteoside A, luteoside B, luteoside C, acteoside and isoacteoside isolated from 
Markhamia lutea exhibited a potent in vitro activity against respiratory syncytial virus, 
11 
an important cause of severe lower respiratory tract infections in infants and young 
children (Keman et al., 1998). Besides the antiviral activity, phenylpropanoid 
glycosides also show the antibacterial activity. Acteoside isolated from Budleja 
cordata was lethal to the bacteria of Staphylococcus aureus by inhibiting the 
admission of leucine, and hence the protein synthesis (Avila et al., 1998). Moreover, 
acteoside, forsythoside B and arenarioside extracted from Ballota nigra exhibited a 
moderate antibacterial activity against Proteus mirabilis and Staphylococcus aureus 
(Didry et al., 1999). 
L4,5.6Antiinflammatory and antinociceptive activities 
Acteoside isolated from Stachytarpheta cayennensis has antiinflammatory 
activity by inhibition on the edema formation after carrageenin subplantar injection 
and by inhibition on histamine- and bradykinin- induced contractions in the guinea-
pig ileum (Schapoval et al., 1998). 
1,4,5.7 Hepatoprotective activity 
It is well recognized that free radicals are involved in various pathological 
conditions. Chemicals such as carbon tetrachloride (CCl4)-catab0lized radicals induce 
lipid peroxidation, damage the membranes of liver cells and organelles, cause the 
swelling and necrosis ofhepatocytes. D-Galacosamine (^-GalN) has been widely used 
as a specific non-radical liver toxin. It selectively traps uridine nucleotides in liver, 
blocks transcription and protein synthesis, and consequently leads to the death of 
hepatocytes. Acteoside, 2'-acetylacteoside, isoacteoside and tubuloside B isolated 
from Cistanche deserticola possessed hepatoprotective activity against the radical 
generator CCl4 and the non-radical but specific liver toxin ^-GalN (Xiong et aL, 1998). 
12 
Moreover, Xiong et al. (1988) stated that acteoside could inhibit hepatic apoptosis, 
hepatitis and lethality induced by p-GalN and lipopolysaccharide (LPS). Acteoside 
also prevented tumor necrosis factor-a (TNF-a)-induced cell death in Q-GalN-
sensitized hepatocytes (Xiong et aL, 1999). 
1.4.5,8 Inhibitory activity of xanthine oxidase 
Xanthine oxidase is a key enzyme associated with the incidence of 
hyperuricemia-related disorders. Isoacteoside isolated from Brandisia hancei was 
found to be the first phenylethanoid glycoside which decreased substantially the 
formation of uric acid by inhibiting competitively xanthine oxidase (Kong et al., 
1999). 
L 4.5.9 Antioxidative and scavenging activities 
Nine phenylethanoid glycoside isolated from Cistache deserticola showed free 
radical scavenging activities on 1,1 -diphenyl-2-picrylhydrazyl (DPPH) radical and 
inhibitory effect on the lipid peroxidation in rat liver microsomes induced by both 
enzymatic and non-enzymatic methods (Xiong et aL, 1996). Moreover, acteoside, 
isoacteoside and phlinoside A extracted from Caryopteris incana exhibited potent 
radical scavenging activity against DPPH, hydroxyl, and superoxide anion radicals 
(Gao et al., 1999). Leucosceposide A and martynoside isolated from Pediculris 
alashanica, and acteoside and pediclariosides M isolated from Pedicularis striata, 
were effective scavengers of superoxide and hydroxyl radicals (Li et aL, 1997a, Wang 
etal., 1996). 
In the present study, the major phenylethanoid glycosides extracted from 
Kudingcha {Ligustrum purpurascens) exhibited strong antioxidatvie activities in 
13 
Cu2+-mediated oxidation ofhuman low-density lipoprotein (LDL). 
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Chapter 2 
Isolation and purification of 
phenylethanoid glycosides in Kudingcha 
2.1 Introduction 
Phenylethanoid glycosides are the natural products usually found in plants. 
Flavonoid has many biological properties which are beneficial to humans, such as， 
antioxidative (Katiyar et cd., 1994)，antimutagenic (Yang & Wang，1993)， 
anticarcinogenic (Wang et al., 1994) and antibacterial activities (Hara & IsMgami, 
1989). Phenylethanoid glycosides are also beneficial to human beings. For examples, 
they have been shown to be anticarcinogenic (Inoue et al., 1998a，Li et al., 1997b, 
Saracoglu et al., 1995), antioxidative (Gao et al.，1999, Ji et al.，1997，Wang et al.， 
1996, Xiong et al., 1996), immunosuppressive (Sasaki et al., 1998), hepatoproective 
(Xiong et al., 1998, 1999)，antibacterial (Avila et al., 1998, Didry et al., 1999, Kernan 
etal., 1998), antiviral, anti-inflammatory (Schapoval etal., 1998)，and antinociceptive 
(Schapoval et al., 1998). They also have DNA-repairing activity (Shi et al., 2000) and 
inhibitory activity to PKC-a (Herbert et al, 1991，Zhou et al,’ 1998). To my best 
knowledge, not many studies have been done on the isolation and purification ofthe 
pure natural products from Kudingcha {Ligustrum purpurascens). He et al (1992) has 
identified and purified seven natural products from Ligustrum purpurascens. They are 
four phenylethanoid glycosides, i.e., acteoside, osmanthuside B，ligupurpuroside A 




The present study was to isolate and purify the known and unknown 
phenylethanoid glycosides from Kudingcha (Ligustrum purpurascens), The 
antioxidative activity and relaxing effects of phenylethanoid glycosides in rat aortic 
rings were tested. 
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2.3Materials and Methods 
2.3.1 Extraction and isolation 
Extraction and isolation of the major components present in Kudingcha were 
carried out according to the method previously described by He et al. (1992). In brief, 
dried leaves (520 g) were extracted with 500 ml ethanol four times under reflux. The 
extract was concentrated under vacuum to give a residue (280 g)，which was then 
dissolved in H^O (Figure 2.1). The extract was fractionated in a column packed with 
Diaion HP-20 (lkg, Mitsubishi kasei) using a mixture of water (10 L) and ethanol (4 
L) as eluting solvents and divided into two factions A1 and A2 were obtained. 
Fraction A1 mainly contained sugar and organic acid components, and fraction A2 
contained crude glycosides. Fraction A2 (42 g) was chromatographed on silical gel (2 
kg) and eluted using chloroform-methanol (CHCl3-MeOH). Four fractions (Bl-B4) 
were subsequently obtained and subjected to a silica gel column chromatography 
using varying ratios of chloroform-methanol (CHCl3-MeOH) as eluting solvent. 
Afterwards, B1 yielded glycoside 2 (132 mg) and five fractions (Cl-C5). Fractions 
Cl-C5 were further purified by LC on Si 60 (Labour 40-63 ^M, 250 x 25 mm Merck) 
and Sephadex LH-20 (100 i^M，Pharmacia Fine Chemical). Fractions C1 and C2 
yielded glycoside 5 (65 mg), fractions Cl，C2 and C3 yielded glycoside 4 (409 mg), 
fractions C4 and C5 yielded glycoside 1 (5126 mg) and fraction C5 yielded glycoside 
3 (632 mg). The separation flow chart was shown in Figure 2.1. The molecular weight 














































































































































































































































































































































































































































































































































































































2.3.2 High performance liquid chromatograph (HPLC) analysis 
2,2.2,1 Acteoside，ligupurpuroside A and osmanthuside B 
Acteoside, ligupurpuroside A and osmanthuside B were analyzed using a 
Shimadzu LC- lOAT HPLC (Tokyo, Japan) equipped with a ternary pump delivery 
system. In brief, 5 t^l of samples (9.9 x 10"^  mg/ml in methanol) was injected onto a 
C18 column (Hypersil ODS, 250 x 4.6 mm, 5 [im, Alltech, Deerfield, JL, USA) in 4 
°C via a rheodyne valve (20 i^l capacity, Shimadzu, Tokyo, Japan). An initial eluting 
mixture ofH2O and acetonitrile (80:20，vol/vol) was used at a flow rate of 1 mVmin. 
From 15 to 43 minutes, the percentage of acetonitrile was increased to 100%. 
Separated glycosides (Figure 2.2) were monitored using a UV detector at 227nm 
(Shimadzu SPD-lOAV, Tokyo, Japan). 
2J.12 cis-Ligupurpuroside B and trans-ligupurpuroside B 
cw-Ligupurpuroside B and ^aw^-ligupurpruposide B were analyzed using a 
Shimadzu LC-lOAT HPLC (Tokyo, Japan) equipped with a ternary pump delivery 
system. In brief, 5 d^ of samples (9.9 x 10_i mg/ml in methanol) was injected onto a 
C18 column (Hypersil ODS, 250 x 4.6 mm, 5 i^m, Alltech, Deerfield, tt>, USA) in 40 
°C via a rheodyne valve (20 i^l capacity, Shimadzu, Tokyo, Japan). An initial eluting 
mixture of H^O and acetonitrile (80.5:19.5, voVvol) was used at a flow rate of 1 
m_l/min. From 15 to 43 minutes, the percentage of acetonitrile was increased to 100%. 
Separated glycosides (Figure 2.3) were monitored using a UV detector at 227nm 
(Shimadzu SPD-lOAV, Tokyo, Japan). 
2.J,J Isolation and purification ofisoacteoside 
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isoacteoside. In brief, 16.1 milligrams of acteoside was dissolved in 100 ml HjO and 
heated at 100 °C. Solution was sampled periodically. Isoacteoside was purified in a 
Sephadex LH-20 column (100 ^M，Pharmacia Fine Chemical Co., Ltd., Germany) 
and analyzed using HPLC (Figure 2.4) and a C-18 column (Hypersil ODS，250 x 4.6 
mm, 5 i^m, Alltech, Deerfield, JL, USA) . The structure of isoacteoside was analyzed 
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Figure 2.4 HPLC chromatograms of acteoside (a) and isoacteoside (b) 
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2.4 Results 
2.4.1 Acteoside (1) 
Powder, [a]D-69.18 (c 0.453, MeOH), C29H3^Oj5.3H2O , found: C 51.35，H 
6.16; calcd: C 51.33, H 6.19; FAB-MS m/z: 647 [M + Na]+, 631 [M + Li]+，625 [M + 
H]+, 416 [M - rhamnosyl]+. UV XMaxnm (log s): 201(4.35)，224(4.27)，247(3.98)， 
289(4.00), 297(4.01)，318(4.38)，332(4.17);DluS cm"^ : 4300，1690，1600，1510， 
1440，1275, 1155, 810; ^ a n d ^¾ NMR are showninTables2.1&2.2. 
2.4.2 Osmanthuside B (2) 
Powder, [a]D- 70.21 (c 0.523, MeOH), C29H36O154H2O , found: C 52.33，H 
6.69; calcd: C 52.41, H 6.63; FAB-MS m/z: 615 [M + Na]+，631 [M + Li]+，593 [M + 
H]+, 416 [M - rhamnosyl]+. UV ^Ma^ nrn (log s): 201(4.23)，224(4.28), 319(4.34); JK 
I)¾¾ cm_l : 4300, 2930，1690, 1600，1510，1440，1260，830; ^ and ^¾ NMR are 
shown in Tables 2.1 & 2.2. 
2.4.3 Ligupurpuroside A (3) 
Powder, [a]D-71.58 (c 0.502, MeOH)，C35H4^O19.2H2O , found: C 52.14，H 
6.21; calcd: C 52.11，H 6.03; FAB-MS m/z: 793 [M + Na]+, 777 [M + Li]+, 771 [M + 
H]+, 594 [M — rhamnosyl]+. UV ^Ma^ nm (log s): 202(4.38), 224(4.08), 333(4.43); JK 
u^?i cm_l : 4300，2928, 1690，1600，1515，1440，1265, 815; 'R and ^¾ NMR are 
shown in Tables 2.1 & 2.2. 
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2.4.4 ^rflfi5-Ligupurpuroside B (4) 
Powder, [a]o-72.16 (c 0.481，MeOH), C35H4^O|7.2H2O , found: C 54.21，H 
6.41; calcd: C 54.26，H 6.46; FAB-MS m/z: 761 [M + Na]+, 745 [M + Li]+，739 [M + 
H]+, 562 [M - rhamnosyl]+. UV Xu^nm (log s): 201(4.45), 224(4.19), 319(4.35); JK 
UMax cm_l : 4300，2930, 1690, 1600, 1510, 1440, 1260, 830; ^ and ^¾ NMR are 
shown in Tables 2.1 & 2.2. 
2.4.5 c/s-Ligupurpuroside B (5) 
Powder, [a]D- 53.47 (c 0.356，MeOH), C35H46O17JH2O，found: C 54.21，H 
6.51; calcd: C 53.03, H 6.57; FAB-MS m/z: 761 [M + Na]+, 745 [M + Li]+，739 [M + 
H]+, 562 [M - rhamnosyl]+. UV Xuf.nm (log e): 201(4.45)，224(4.19), 319(4.35); JK 
UMa^  cm_l : 4300，2930, 1690, 1600, 1510, 1440, 1260，830; 'U and '^ C NMR are 
shown in Tables 2.1 & 2.2. 
2.4.6 Isoacteoside (6) 
2.4,6.1 Thermal stability 
The formation ofisoacteoside was examined as shown in Figure 2.5. The results 
showed that the longer the incubation time, the greater the epimerization of acteoside 
to isoacteoside. The formation of isoacteoside was 41.7% in the first hour of 
incubation and the amount of acteoside decreased to 58.3% during the same 
incubation time. After 6 hours, there was not much change of the percentage of 
formation ofisoacteoside. The amount of isoacteoside formed was 84.3%，86.8% and 
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Figure 2.5 Conversion of acteoside to isoacteoside at 100 °C 
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2.5 Discussions 
2.5.1 Acteoside (1) 
The molecular formula of acteoside is C29H36O15 [FAB mass spectrum (m/z 625 
[M + H]+)]. The UV absorption [xSSnm (log e): 201(4.35)，224(4.27), 247(3.98)] 
and n i spectrum (uM?x cm"^ : 3400，1690, 1600，1510) suggested the presence of 
hydroxyl, ester and conjugated aromatic groups. H^ NMR spectrum at the aromatic 
region exhibited ABX system belonging to caffeoyl and phenylethanoyl moiety 
[5 7.064 (lH, d, 2.0)，5 6.785 (lH, d, 8.4)，5 6.958 (lH, dd，8.4，2.0), 5 6.699 (lH, d， 
2.0)，5 6.881 (IH，d，8.2), 5 6.565 (lH, dd, 8.2, 2.0)] respectively (Tables 2.1 & 2.2). 
^ NMR signals oftwo anomeric protons at 5 5.185 (lH, d，1.2) and 5 4.381 (lH, d, J 
=7.9 Hz), as well as one secondary methyl groups of rhamnose at 5 1.091 (3H, d,J = 
6.1 Hz) suggested that there were one a - L - rhamnoses and one P - D - glucose. 
Acteoside was confirmed as 2- (3，4- dihydroxyphenyl)- ethyl- [3- 0- a- L-
rhamnopyranosyl] [4- 0_ E-caffeoyl] - 0_ p- D_ glucopyranoside (Figure 2.6). 
2.5.2 Osmanthuside B (2) 
The molecular formula of osmanthuside B is C29H36O13 [FAB mass spectrum 
(m/z 593 [M + H]+)]. The UV absorption [Xu^nm (log s): 201(4.23), 224(4.28), 
319(4.34)] and JK spectrum (uMax cm"^  : 3400, 1690，1600, 1510) suggested the 
presence ofhydroxyl, ester and conjugated aromatic groups.�H NMR spectrum at the 
aromatic region exhibited A2B2 system belonging to p — coumaroyl and 
phenylethanoyl moiety [5 6.806, 6.686 (4H, d，8.7); 5 7.462, 7.071 (4H, d, 8.6)]， 
respectively (Tables 2.1 & 2.2). ^ NMR signals of two anomeric protons at 5 5.178 
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(lH, d, 1.6) and 5 4.377 (lH, d，J= 8.0 Hz), as well as one secondary methyl groups 
of rhamnose at 5 1.074 (3H, d，J = 6.1 Hz) suggested that there were one a - L -
rhamnoses and one P - D - glucose. Osmanthuside B was confirmed as 2- (4-
hydroxyphenyl)- ethyl- [3- 0- a_ L- rhamnopyranosyl] [4- 0- E- p- coumaroyl] - 0_ 
P_ D- glucopyranoside (Figure 2.6). 
2.5.3 Ligupurpuroside A (3) 
The molecular formula of ligupurpuroside A is C35H46O19 [FAB mass spectrum 
(m/z 771 [M + H]+)]. The UV absorption [Xu^nm (log s): 202(4.38)，224(4.08)， 
333(4.43)] and 瓜 spectrum ( u S i cm"^  : 3400，1690，1600, 1510) suggested the 
presence ofhydroxyl, ester and conjugated aromatic groups. ^ NMR spectrum at the 
aromatic region exhibited ABX system belonging to caffeoyl and phenylethanoyl 
moiety [5 7.702 (lH, d, 2.0), 6 6.811(1H, d, 8.2), 5 6.854 (lH, dd, 8.2，2.0), 
5 6.751 ( m , d , 1.9),5 6.694 (lH, d, 8.1)，5 6.575 (lH, dd, 8.1，1.9)] respectively 
(Tables 2.1 & 2.2). (H NMR signals of three anomeric protons at 5 5.071 (lH, d，1.6), 
5 5.215 (lH, d, 1.3) and 6 4.380 (lH, d , J = 8.0 Hz), as well as two secondary methyl 
groups of rhamnose at 5 1.076 (3H, d , J = 6.1 Hz) and 5 1.108 (3H, d,J= 6.1 Hz) 
suggested that there were two a - L - rhamnoses and one P _ D _ glucose. 
Ligupurpuroside A was confirmed as 2- (3，4- dihydroxyphenyl)- ethyl- [3- 0- a- L-
rhamnopyranosyl (1 — 4) - a- L_ rhamnopyranosyl] [4- 0-五-caffeoyl] - 0- p- D-
glucopyranoside (Figure 2.6). 
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2.5.4 ^ran^-Ligupurpuroside B (4) 
The molecular formula of /raw^-ligupurpuroside B is C35H46O17 [FAB mass 
spectrum (m/z 739 [M + H]+)]. The UV absorption [XMSnm (log s): 201(4.45)， 
224(4.19), 319(4.35)] and ER. spectrum (uMa^  cm"^ : 3400, 1690，1600，1510) 
suggested the presence of hydroxyl, ester and conjugated aromatic groups. ^ NMR 
spectrum at the aromatic region exhibited A2B2 system belonging to p - coumaroyl 
and phenylethanoyl moiety [5 6.851, 6.731 (4H, d, J= 8.7 Hz); 5 7.101, 7.517 (4H, d, 
J= 8.7 Hz)], respectively (Tables 2.1 & 2.2). The two olefinic proton signals which 
appeared as an AB - system {J = 15.9 Hz) indicated a trans geometry.�H NMR 
signals of three anomeric protons at 5 5.241 (lH brs)，5 5.064 (lH, brs) and 5 4.413 
(IH，d, J= 7.8 Hz), as well as two secondary methyl groups of rhamnose at 5 1.065 
(3H, d，J = 6.0 Hz) and 5 1.114 (3H, d, J = 6.0 Hz) suggested that there were two a -
L - rhamnoses and one P - D - glucose.如似-Ligupurpuroside B was confirmed as 2-
(4- hydroxyphenyl)- ethyl- [3_ 0- a- L- rhamnopyranosyl (1 ~> 4) — a_ L-
rhamnopyranosyl] [4- 0- E- p- coumaroyl] - 0- P_ D- glucopyranoside (Figure 2.6). 
2.5.5 d5-Ligupurpuroside B (5) 
The molecular formula of cw-ligupurpuroside B is C35H46O17 [FAB mass 
spectrum (m/z 739 [M + H]+)]. The UV absorption [Xu^nm (log s): 201 (4.45), 224 
(4.19)，319 (4.35)] and JR spectrum (uMax cm"^ : 3400, 1690，1600, 1510) suggested 
the presence ofhydroxyl, ester and conjugated aromatic groups.�H NMR spectrum at 
the aromatic region exhibited A2B2 system belonging to p — coumaroyl and 
phenylethanoyl moiety [5 6.799, 6.729 (4H，d,J= 8.7 Hz), 6 7.101，7.757 (4H, d，J = 
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8.7 Hz)], respectively (Tables 2.1 & 2.2). The two olefinic proton signals which 
appeared as an AB - system (J= 12.9 Hz) indicated a cis geometry. ^ NMR signals 
ofthree anomeric protons at 5 5.161 (lH brs)，6 5.327 (lH, brs) and 5 4.387 (lH, d，J 
=7.8 Hz), as well as two secondary methyl groups of rhamnose at 6 1.234 (3H, d, J = 
6.0 Hz) and 5 1.250 (3H，d, J = 6.0 Hz) suggested that there were two a - L -
rhamnoses and one P - D - glucose. cw-Ligupurpuroside B was confirmed as 2- (4-
hydroxyphenyl)- ethyl- [3 -0-a-L-rhamnopyranosyl (1 ~> 4) - a- L- rhamnopyranosyl； 
[4_ 0- E- p- coumaroyl] - 0- P_ D- glucopyranoside (Figure 2.6). 
2.5.6 Isoacteoside (6) 
The molecular formula ofisoacteoside is C29H36O15 basis on FAB mass spectrum 
(m/z 625 [M + H]+). ^ NMR spectrum at the aromatic region exhibited ABX system 
belonging to caffeoyl and phenylethanoyl moiety [5 7.069 (IH，d，2.1)，5 6.798 (lH, d, 
8.1), 5 6.923 (lH, dd，8.1, 2.1), 5 6.703 (lH,d, 1.8)，5 6.666 (lH, d, 8.1), 5 6.564 (lH, 
dd，7.8, 1.8)], respectively (Table 2.1 & 2.2). ^ NMR signals of two anomeric 
protons at 5 5.211 (lH, d，1.2) and 5 4.365 (lH, d , J = 7.8 Hz), as well as one methyl 
groups ofrhamnose at 5 1.278 (3H, d, J = 6.0 Hz) suggested that there were one a - L 
-rhamnoses and one P - D - glucose. The ^^C-NMR of isoacteoside was close to those 
of acteoside, but slight differences were observed in the chemical shifts at the C-3 and 
C-6 carbons of glucosyl group (Tables 2.1 & 2.2 and Figure 2.7). The signal of C-3 
and C-6 of the glucosyl moiety is shifted downfield from 5 81.66 to 5 84.45 and 
5 62.49 to 6 65.20 respectively in isoacteoside (Table 2.2). Thus, the caffeoyl group 
should be located at the C-6 of the glucosyl moiety in isoacteoside. The glycoside was 
identified as 2_ (3, 4_ dihydroxyphenyl)- ethyl- [3- 0- a- L_ rhamnopyranosyl] [6- 0-
30 
E- p- caffeoyl] -0- P_ D- glucopyranoside and was identified as isoacetoside (Figures 
2.6 & 2.7). 
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Figure 2.6 Chemical structures of acteoside (1)，osmanthuside B (2)，Hgupurpuroside A (3)， 












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2.2 ^^ C NMR spectral data ofacteoside (1), osmanthuside B (2)，ligupurpuroside A 
(3), /ra/7^-ligupurpuroside B (4)，c/^-ligupurpuroside B (5) and isoacteoside (6) 
(CD3OD) 
Phenylethanoid glycosides 
_C 1 2 3 4 5 6 
Aglycone 
1 131.60 130.65 131.63 130.78 130.72 131.95 
2 116.40 130.88 116.39 130.89 130.85 116.94 
3 144.62 116.14 144.64 116.18 116.09 145.25 
4 146.08 156.57 146.11 156.66 156.52 146.72 
5 117.17 116.14 117.17 116.18 116.09 117.13 
6 121.31 130.88 121.30 130.89 130.85 121.85 
7 36.51 36.32 36.53 36.27 36.21 37.16 
8 72.34 72.19 72.18 72.27 72.24 72.93 
Glucosyl 
1 104.19 104.10 104.94 104.11 104.01 104.97 
2 76.0 1 75.93 76.00 75.92 75.91 75.99 
3 81.66 81.58 81.43 81.60 81.25 84.45 
4 70.69 70.64 70.58 70.57 70.38 70.94 
5 76.18 76.09 76.27 76.15 76.05 76.31 
6 62.49 62.34 62.38 62.33 62.25 65.20 
Rhamnosyl 
1 102.96 102.93 103.31 103.37 103.32 103.29 
2 72.11 72.01 72.37 72.27 72.25 72.82 
3 72.34 72.15 70.58 70.57 70.25 73.04 
4 73.83 73.76 81.33 81.51 81.24 74.57 
5 70.69 70.31 68.61 68.83 68.79 70.61 
6 18.40 18.36 19.11 19.08 19.15 18.47 
Rhamnosyl 
1 102.53 102.60 102.57 
2 72.87 72.77 72.75 
3 72.46 72.19 72.23 
4 73.89 73.75 73.47 
5 70.28 70.27 70.28 
6 17.68 17.66 17.64 
caffeoyl (trans) 
1 127 72 127.62 128.17 
2 115.38 115.44 115.60 
3 146.77 146.77 147.43 
4 149.72 149.85 150.37 
5 116 40 116.39 117.66 
6 123.18 123.34 147.90 
7 148.00 147.90 115.19 
8 114.78 114.80 169.77 




1 127.04 127.00 127.46 
2 6 131.26 131.37 134.18 
3，5 116.81 117.08 115.76 
4， 161.26 161.33 160.24 
7 147.55 147.58 147.21 
8 114.67 114.74 115.93 
CO 168.18 168.17 166.96 
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Chapter 3 
Inhibitory effects of phenylethanoid glycosides 
isolated from Kudingcha on Cu^^-mediated LDL 
oxidation in vitro 
3.1 Introduction 
Cardiovascular disease is a leading cause of mortality in world (Grundy, 1990). 
An increased concentration of plasma low-density lipoprotein cholesterol (LDL-C) 
constitutes a major risk factor for atherosclerosis. It is believed that acetylated and 
oxidized LDL (ox-LDL) may play an important role in the development of 
atherosclerotic lesions (Nielsen, 1999). The modified forms ofLDL are three to ten 
times more rapid being uptaken via the scavenger receptor in macrophages than the 
native LDL (Henriksen et a/.，1981). Foam cells are then formed when macrophages 
are trapped in the arterial intima after taking up the modified LDL (Steinberg et al., 
1989). As a result of lipid deposits in foam cells, the arterial wall evolves from the 
initial fatty streak to the more complex fibrofatty or atheromatous plaque (Ross et al., 
1986). The lateral or shoulder areas of these plaques are prone to plaque rupture, 
which triggers thrombosis and finally atherosclerosis. 
3.2 Mechanisms of lipoprotein oxidation in vivo 
3.2.1 Oxidants underlying LDL oxidation 
The mechanism by which LDL becomes oxidized in vivo is unclear and 
controversial ( Berliner & Heinecle，1996). It has been postulated that intimal cells 
can produce and secrete free radicals and reactive oxygen species such as the 
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superoxide anion. These species are able to initiate the self-propagating chain 
reactions in native LDL and lead to the production of oxidized LDL (Sharma et al., 
1992). It has also been postulated that lipoxygenase are responsible for lipid oxidation 
in vivo (Yla-Herttuala et cd., 1991). Myeloperoxidase secreted by neutrophils and 
monocytes, may also oxidize LDL by acting as a physiological catalyst (Hazell & 
Stocker，1993). Furthermore, reactions requiring metal ions, such as iron and copper, 
are an important pathway for LDL oxidation (Jial & Devaraj，1996). The above 
mechanisms are not mutually exclusive, and it is probable that LDL oxidation arises 
by several routes. 
3.2.2 Oxidative modification of LDL 
Oxidation of LDL is a free radical-mediated process which depends on a 
common initiating event, the peroxidation of polyunsaturated fatty acids (PUFAs) in 
LDL. Oxidation ofLDL is initiated by reactive oxygen species that abstract a proton 
(H*) from a double bond in PUFA. This results in molecular rearrangement and leads 
to form conjugated diene (Esterbauer et al., 1992). A rapid propagation phase is 
followed in which the abstraction of another proton from another PUFA by a PUFA-
peroxyl radical, resulting in the formation of lipid peroxides. The oxidation of LDL 
may be terminated by the interaction of one free radical with another. 
Protein moiety is also chemically modified during the oxidation of LDL 
(Esterbauer et al., 1992). The aldehydes, resulting from the cleavage of double bonds 
in PUFAs in LDL, react with the 8-amino group of lysine residues in apoprotein B, 
forming Schiffs bases and leading to an increase in the negative net charge ofLDL 
particle (Steinbrecher, 1987). As a result, oxidatively modified LDL is no longer 
recognized by native LDL receptor (Brown & Goldstein et al., 1986), but it is taken 
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up by monocyte/macrophages via the scavenger receptor pathway (Sparrow et al., 
1989). 
3.2.3 Role of oxidatively modified LDL in atherogenesis 
In the early phase of oxidation, mild oxidation ofLDL results in the formation of 
minimally modified LDL (MM-LDL) in the subendothelial space. Once formed, MM-
LDL may be able to induce the endothelium to express adhesion molecules for 
monocytes and to secrete monocyte chemotactic protein-1 (MCP-1) and macrophage 
colony stimulation factor (M-CSF) (Berliner et al., 1995). These events result in 
monocyte binding to endothelium and subsequent migration, mediated by MCP-1, of 
monocyte into the subendothelial space. There, MM-LDL promotes monocyte 
differentiation into macrophages via M-CSF. The mature macrophage, in turn, 
modifies MM-LDL to the more oxidized form. This Ox-LDL is no longer recognized 
by the LDL receptor, instead it is taken up by the scavenger receptor on the 
monocyte-macrophages, and this uptake is not regulated by intracellular cholesterol 
content (Brown & Goldstein, 1983). This results in appreciable cholesterol 
accumulation within the macrophages，resulting in foam cell formation. Because ox-
LDL is a potent chemoattractant for circulation monocytes, it may promote 
macrophage retention in the arterial wall and recruit more monocytes into the area. A 
schematic depiction ofthe role of ox-LDL in atherogenesis is shown in Figure 3.1. 
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Figure 3.1 Oxidized LDL in atherogenesis. Native LDL becomes trapped in the 
subendothelial space, where it can be oxidized by resident vascular cells such as 
smooth muscle cells, endothelial cells, and macrophages. Oxidized LDL induces 
monocyte chemotaxis (A). Monoctyes differentiate into macrophages that internalize 
oxidized LDL, leading to foam-cell formation (B). Oxidized LDL also causes 
endothelial dysfunction and injury (C), as well as foam-cell necrosis (D) (Adapted 
from Franklin et al., 1997). 
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3.2.4 Antioxidants and atherosclerotic heart disease 
Epidemiological data suggest the dietary and supplemental antioxidant vitamins 
reduce the clinical manifestations of atherosclerosis. Initially, these data were limited 
to descriptive studies in European and North American populations. Subsequent case-
control studies indicated that patients with angina pectoris have lower plasma 
concentrations of vitamin E than normal subjects. It is also known that reduced 
concentrations of vitamin C in the leukocytes are predictive of angiographically 
evident coronary artery disease. 
Several studies have investigated the ability of various antioxidant compounds to 
prevent atherogenesis in animals. Probucol is a lipid-soluble cholesterol-lowering 
drug with potent antioxidant properties (Reaven et al., 1992). When fed to Watanabe 
hereditary hyperlipidemic (WHHL) rabbits, it inhibits the formation of atherosclerotic 
lesions independently of its cholesterol lowering properties (Carew et aL, 1987)，and 
LDL derived from rabbits given probucol is more resistant to oxidation than LDL 
from control rabbits (Kita et al., 1987). 
Many clinical studies have investigated the effects of antioxidant 
supplementation in humans on LDL oxidation in vivo. The administration of lipid-
soluble antioxidants such as a-tocopherol or probucol is associated with their 
incorporation into LDL and a concomitant increase in the resistance of LDL to 
oxidative modification. In contrast, supplementation with beta carotene does not 
protect LDL from oxidation (Gaziano et al., 1995, Reaven et al., 1993), suggesting 
that different vitamin antioxidants function differently in human LDL. 
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3.2.5 Measuring the thiobarbituric acid-reactive substances (TBARS) 
formation as an index of LDL oxidation 
Measurement of TBARS formation is an in vitro index for the lipid peroxidation. 
Although measurement of TBARS has some limitations, it is still frequently used. It 
can give relatively good sensitivity and reproducible results with LDL in cell-present 
and cell- free systems (Puhl et al., 1994). Malondialdehyde (MDA), a highly reactive 
dialdehyde, is formed from the breakage of the conjugated diene or double bonds of a 
polyunsaturated fatty acid (PUFA) during LDL oxidation. Two molecules of 
thiobarbitric acid (TBA) under acidic condition react stoichiometrically with one 
molecule of MDA to form a pink chromagen, which has an absorption maximum in 
acid solution at 532 to 535 nm. This acidic condition is maintained by the addition of 
trichloroacetic acid (TCA) solution and hydrocholic acid (Ohkawa et al, 1978 & 
Janero etal., 1990). 
3.2.6 Effect of flavonoids on Cu^^-mediated human LDL oxidation 
It has demonstrated that the antioxidant activities of the flavonoids are governed 
by their hydrogen-donating free radical scavenging and their resonance structure 
dependence (Rice-Evans et al., 1996). The ability of flavonoids to inhibit the 
oxidation of LDL demonstrates their potential as chain-breaking antioxidants 
(Mangiapane, et al., 1992; Miura, et al., 1995; Salah et a/., 1995). The antioxidant 
activity of flavonoids might involve a role in sparing of a-tocopherol. Other studies 
suggest that polyphenols might inhibit free radical formation and propagation through 
the chelation oftransition-metal ions, particularly those of iron and copper (van Acker 
et al., 1996). In transition-metal-free lipid systems, the phenolics act as antioxidants 
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by virtue of their ability to act as hydrogen donors, leading to the formation of 
aryloxyl radicals. In the presence of transition metal ions, however, it is still not clear 




The objective of the present study was to examine the antioxidative activity of 
several phenylethanoid glycosides isolated from Kudingcha on Cu^ -^mediated human 
LDL oxidation in vitro. The possible mechanism of their anti-LDL oxidation was also 
examined. 
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3.4 Materials and methods 
3.4.1 LDL isolation 
Fresh blood was collected from healthy subjects at the Prince of Wales Hospital, 
The Chinese University of Hong Kong, Shatin, Hong Kong. To prevent lipoprotein 
modification, EDTA and NaN^ were added to freshly prepared plasma (final 
concentration of EDTA and NaN^ were 0.1% and 0.05%，respectively). LDL was 
isolated from plasma according to the method described previously (Havel et al., 
1995). To minimize the oxidation of LDL, the centrifuge tubes containing plasma 
were flushed with nitrogen gas. Firstly, the plasma was centrifuged at 1500 g for 15 
minutes to remove cells and cell debris. NaCl-KBr solution (dissolve 153 g NaCl, 354 
g KBr and 100 i^g EDTA in one liter of water, 1.33gAnl) was then added to increase 
the plasma density to 1.019. The plasma was re-centrifuged at 160,000 g at 10 °C for 
20 hours. After removing the top layer containing chylomicron and very low-density 
lipoprotein (VLDL), the density of remaining plasma fractions was increased to 1.064 
and re-centrifuged at 160,000 g for an additional 24 hours. The top LDL fraction was 
collected and then flushed with nitrogen and stored at -70 °C. The protein content of 
isolated LDL was determined using Lowry's method (Lowry et al., 1951). 
3.4.2 LDL oxidation 
The stock LDL fraction (5 mg proteinAnl) was dialyzed against 100 volumes of 
the degassed dialysis solution (pH = 7.4) containing 0.01 M sodium phosphate, 0.9% 
NaCl，10 i^M EDTA and 0.05% NaN� in dark for 24 hours. The dialysis solution was 
changed four times. Oxidation ofLDL was conducted as previously described by Puhl 
et aL (1994). LDL protein (100 i^g) was incubated in a mixture containing 5 ^M 
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CuSO^ at 37 °C for up to 32 hours. The oxidation was then stopped by addition of 25 
i^l 1.0% EDTA and cooled at 4 °C. 
3.4.3 Thiobarbituric acid-reactive substances (TBARS) assay 
The degree of LDL oxidation was monitored by measuring the production of 
TBARS as previously described (Buege & Aust, 1978). After the reaction was 
stopped by addition of EDTA at 4 °C，2 ml of 0.67% thiobarbituric acid and 15% 
trichloroacetic acid in O.lN HC1 solution were added to the LDL-incubated tube. The 
incubation mixture was then heated at 95°C for 1 hour, cooled on ice, and centrifuged 
at 1000 g for 20 minutes. TBARS was determined by measuring the absorbance at 
532 nm. Calibration was done with a malondialdehyde (MDA) standard solution 
prepared from tetramethoxylpropane. The value was expressed as nmol MDA/mg 
LDL protein. 
3.4.4 Interactions of phenylethanoid glycosides isolated from 
Kudingcha with Cu!+ in human LDL oxidation 
Stock solutions of each Kudingcha pheynlethanoid glycosides (lmM) were 
prepared in water. Then the solution was diluted to 250 i^M in a cuvette and the 
absorption spectra were recorded between 200 and 350 nm. Scans with addition of 
250 and 500 i^M CuSO4 were taken after 10 seconds and compared with each 
Kudingcha phenylethanoid glycosides alone. 
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3.3.5 Statistics 
Results are expressed as mean 士 standard deviation (SD). One way analysis of 
variance (ANOVA) and Student's ^test were used where applicable for statistical 




3.5.1 Protective effect ofthe major phenylethanoid glycosides isolated 
from Kudingcha on LDL oxidation 
LDL was oxidized significantly within 4 hours. cw-Ligupurpuroside B，trans-
ligupurpuroside B and osmanthisde B (40 i^M) demonstrated no or little protection to 
LDL from Qj2+ -mediated oxidation (Figure 3.2). LDL was oxidized completely at 10 
hours in the presence of cw-ligupurpuroside B，/ra/75-ligupurpuroside B and 
osmanthuside B at the concentration of 40 [xM. On the other hand, LDL did not show 
any oxidation throughout the period of30 hours in the presence of 40 i^M of acteoside, 
isoacteoside and ligupurpuroside A. In the presence of 40 i^M epicatechin gallate 
(ECG), one of the major antioxidants in green tea as a reference，LDL also did not 
show any oxidation ofhuman LDL throughout 30 hours (Figure 3.2). 
3.5.2 Varying protective effect of individual major Kudingcha 
phenylethanoid glycosides 
Acteoside, isoacteoside and ligupurpuroside A, demonstrated a dose- dependent 
antioxidant activity in Cu2+-promoted LDL oxidation (Figures 3.3 & 3.4). Under the 
same conditions, these three phenylethanoid glycosides had similar antioxidative 
activities against LDL oxidation. To be more specific, LDL was rapidly oxidized to 
reach its maximum TBARS level within 4 hours. In contrast, LDL began to oxidize at 
12 hours when 10 i^M acteoside and ligupurpuroside A were added. When 20 i^M of 
acteoside and ligupurpuroside A was added, the lag-time was extended to 24 hours. In 
the case ofisoacteoside, the lag-time for production ofTBARS was only extended to 
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Figure 3.2 Inhibitory effect of the purified phenylethanoid glycosides from 
Kudingcha on the production of thiobarbituric acid reactive substances (TBARS) in 
Cu2+-mediated oxidation of human LDL. Data are expressed as mean 士 SD of n=4. 
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Figure 3.4 Inhibitory effect of ligupurpuroside A on the production of thiobarbituric 
acid reactive substances (TBARS) in Cu^^-mediated oxidation of human LDL. Data 
are expressed as mean 土 SD of n=4. Means at the same time point with different 
letters (a-e) differ significantly (p<0.01). 
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15 hours instead. When the concentration of these three phenylethanoid glycosides 
was increased to 40 ^iM, L D L did not show any oxidation throughout the period o f30 
hours (Figures 3.3 & 3.4). 
3.5.3 Interactions of Kudingcha phenylethanoid glycosides with Cu!+ 
in human LDL oxidation 
The direct interactions of the Kudingcha phenyletanoid glycosides wi th Cu^+ ion 
were assessed by U V / visible spectroscopy. The results were shown in Figures 3.5 -
3.7. The peak position of band I and band I I of acteoside was 215 nm and 325 nm 
respectively. For isoacteoside，the peak position o f band I and I I was similar to 
acteoside alone. They were 215 nm and 330 nm respectively. The band I peak 
position of ligupurpuroside A was 210 nm and band I I was 305 nm. Similar peak 
position was observed in osmanthuside B, the band I and band I I peak positions were 
215nm and 295nm respectively. Not much difference was observed in the peak 
position of band I and band I I of cw-ligupurpuroside B and ^aw^-ligupurpuroside B. 
The band I and band I I peak positions of cz5-ligupurpuroside B and trans-
ligupurpuroside B were 225 nm and 310 nm respectively. Interactions of Cu^+ ion 
wi th the Kudingcha phenylethanoid glycosides at 1:1 and 2:1 ratios did not produce 
any bathochromic shifts in the spectrum of the six phenylethanoid glycosides. The 
peak positions o f band I and I I of these six phenylethanoid glycosides remained the 
original after adding one and two times amount of Cu^+ ions to the phenylethanoid 















































































































































































































































































































































































































































































































































































































































































































































































The Zutphen Elderly Study by Hertog et al. (1993) showed an inverse 
association between flavonoid consumption and coronary heart disease mortality after 
adjustment for age, diet and other risk factors including history of myocardial 
infarction, intake of total energy, intake of saturated fatty acids, physical activity, 
body-mass index, smoking, serum total cholesterol, and systolic blood pressure. This 
is because that dietary antioxidants may attenuate the progress of atherosclerosis and 
delay the autoxidation by inhibiting formation of free radicals, interrupting the 
propagation of the free radicals chain reaction and protecting L D L from oxidative 
modification. 
Kudingcha is widely consumed in southern China. Drinking Kudingcha is as 
much as the green tea in southern China. I t is wel l known that many benefits are 
associated wi th drinking green tea, but not many studies have been done on 
Kudingcha. In the present study, we have examined the antioxidative activity of the 
phenylethanoid glycosides isolated from Kudingcha (Ligustrum purpurascens) on 
Cu2+-mediated L D L oxidation. It demonstrated that acteoside, isoacteoside and 
ligupurpuroside A were as effective as ECG in the protection of human L D L from 
Cu2+-mediated oxidation. Under the same conditions, the other three phenylethanoid 
glycosides, cw-ligupurpuroside B，^raw^-ligupurpuroside B and osmanthuside B 
showed little or no protection to human LDL. HPLC analysis demonstrated that 
acteoside and ligupurpuroside A were two major phenylethanoid glycosides in 
Kudingcha, implying that these two phenylethanoid glycosides are probably 
responsible for the antioxidant activity ofKudingcha. Isoacteoside, naturally absent in 
Kudingcha, was converted from acteoside when the latter was heated at 100°C. 
Acteoside and ligupurpuroside A accounted for 2.76% of total ethanol extract while, 
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cw-Ligupurpuroside B, /raw^-ligupurpuroside B and osmanthuside B accounted for 
0.75% of total ethanol extract. The Kudingcha ethanol extract also demonstrated to 
inhibit L D L from oxidation. 
L D L can be protected from oxidation by its endogenous antioxidants including 
a-tocopherol, retinoids, and carotenoids. Therefore the oxidation of L D L only occurs 
under certain circumstances when the L D L particle is depleted of its endogenous 
antioxidants. The mechanisms by which the three effective penylethanoid glycosides 
inhibit Cu^^-mediated human L D L oxidation are under investigation. The next chapter 
would examine whether the Kudingcha phenylethanoid glycosides could protect the 
L D L endogenous a-tocopherol. The present experiment only addressed that whether 
these Kudingcha phenylethanoid glycosides Rinctioned as chelators to inactive Cu^+ 
and other ions involved in initiation of free radicals. Addit ion o f Cu】+ did not cause 
any major spectral changes of the Kudingcha phenyethanoid glycosides at the 
wavelength of 200 nm to 400 nm, suggesting that these Kudingcha phenylethanoid 
glycosides cannot chelate Cu^^ to inhibit the initiation of free radicals. This indicates 
that the Kudingcha phenylethanoid glycosides may function as a primary antioxidant 
2 1 
instead by directly reducing the formation of free radicals mediated by Cu . 
The present results demonstrated that acteoside, isoacteoside and ligupurpuroside 
A were more effective than cw-ligupurpuroside B，/raw^-ligupurpuroside B and 
osmanthuside B against L D L oxidation. Perhaps an additional hydroxyl group (Figure 
2.6) makes acteoside, isoacteoside and ligupurpuroside A more vulnerable to donate a 
hydrogen than cw-ligupurpuroside B, /raw5-ligupurpuroside B and osmanthuside B. 
Acteoside, isoacteoside and ligupurpuroside A are structurally similar，so is their 
antioxidant activity. This was reflected by having a similar lag time in L D L oxidation 
under the same concentration. 
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The protective effects of Kudingcha phenylethanoid glycosides against L D L 
oxidation implicate that they may serve as dietary sources of anti-atherogenic agents 
i f they can be systemically absorbed. Further studies should be done on the absorption 
of these pure glycosides and their metabolism. 
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Chapter 4 
Inhibitory effects of Kudingcha phenylethanoid 
glycosides on a-tocopherol oxidation in vitro 
4.1 Introduction 
4.1.1 LDL oxidation and atherosclerosis 
Oxidative modification of low-density lipoprotein (LDL) can lead to an 
increased and uncontrolled uptake of cholesterol by macrophages. (Steinbrecher et al., 
1987). The uptake of oxidized L D L is perhaps a crucial step in a cascade of cellular 
processes which lead to the formation of fatty streaks and eventually atherosclerotic 
lesions in the artery wal l (Steinberg et al, 1997). Thus, much attention has been 
devoted to maintain a high level o f L D L endogenous and exogenous antioxidants 
(Esterbauer et al., 1990; Gey et al,, 1992). a - Tocopherol is biologically and 
chemically the most active form of vitamin E (Burton et al., 1986). It is the major 
lipid-soluble radical-trapping antioxidant in plasma (Burton et al., 1986) and L D L 
(Esterbauer et al., 1990) in human LDL. Other antioxidants are quantitatively minor 
including 丫 - tocopherol, carotenoids, retinol and ubiquinol-10 (Esterbauer et al., 
1990). I t has been reported that increased vitamin E intake has been shown to be 
associated wi th the reduced oxidation of LDL, platelet adhesiveness，and thrombosis 
(Hodis et al., 1995; Jialal and Grandy, 1992; Kritchevsky et al., 1995; Princen et al., 
1992; Reaven et al, 1993; Stanley et al., 1996). Epidemiological data suggest that 
vitamin E supplementation is associated with a lower risk of coronary heart disease in 
both men and women (Losonczy et al., 1996; Rimm et al., 1993; Stampfer et al., 
1993). Growing evidence for a protective effect of vitamin E in humans also includes 
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an inverse association between plasma a - tocopherol and mortality from 
cardiovascular heart disease (Gey et al., 1992; Riemersma et al., 1991). In this regard, 
a-tocopherol may play an important role in preventing L D L oxidation and lowering 
the risk of cardiovascular diseases. In contrary, there is no association of coronary 
disease wi th the supplementary of vitamin C and carotene (Losoczy et al., 1996; 
Rimm et al., 1993; Stampfere/ al., 1993). 
4.1.2 Role of vitamin E in LDL lipid peroxidation 
The peroxidation of lipid-containing bisallylic hydrogens (LH) in homogeneous 
solution proceeds via the radical chain mechanism. The process is initiated by the 
abstraction of a relatively weakly bound bisallylic hydrogen on the lipid moiety to 
produce a carbon-centered lipid radical (L*), which rapidly combines with oxygen to 
produce a lipid peroxyl radical ( L 0 0 . ) . Reaction of LOO® with another L H gives 
rise to lipid hydroperoxide (LOOH) while regenerating L 0 0 * , the chain-propagating 
species. It is illustrated by the following reactions 1-3. 
Initiation radical oxidant + L H ^ inactive oxidant + L* (1) 
Propagation L* + O〗 • LOO* (2) 
PropagationLOO* + LH • LOOH + L* (3) 
In the absence of chain-breaking antioxidants such as a-tocopherol, lipid 
peroxidation may terminate via bimolecular processes. It is shown in the following 
reaction 4. 
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Termination LOO* + L 0 0 * / L * ^ nonradical products (4) 
a-Tocopherol (a- TOH) acts as a chain-breaking antioxidant by donating its 
phenolic hydrogen to the otherwise chain-propagating LOO* and replacing the latter 
with the less reactive a-tocopheroxyl radical (a- T 0 * ) (reaction 5) (Burton et al., 
1986). Alternatively, a_ TOH may react directly wi th the initiating radical (reaction 6) 
to prevent LOO* formation. LOO* may also be eliminated via a radical-radical 
reaction wi th a - TO* (reaction 7). 
Inhibition a - TOH + LOO* • a- TO* + LOOH (5) 
Inhibition a- TOH + radical oxidant • inactive oxidant + 
a - TO* (6) 
Termination a- TO* + LOO* • nonradical products (7) 
The antioxidant activity of a- TOH described above gives rise to a well-defined 
period of strong inhibition of l ip id peroxidation, termed as the ‘lag time' (Burton et al., 
1986). After complete depletion of a- TOH, the rate of lipid peroxidation increases 
rapidly. The key characteristic of vitamin E action under these conditions is that 
increasing its content results in enhanced inhibition on lipid peroxidation, reflected by 
a prolonged lag time. 
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4.1.3 Interactions of a-tocopherol with other antioxidants and 
synergists 
When more than a single antioxidant are present in an oxidizing lipid system, 
their net antioxidant effect is frequently more than the sum of their individual effects 
(a phenomenon known as synergism). It can be recognized at least three mechanisms 
by which synergism of the tocopherols with other antioxidants can be explained. 
The first mechanism occurs when a-tocopherol is present with another 
antioxidant, which can spare a-tocopherol by the same or by a different mechanism 
(i.e., a radical scavenger or a singlet oxygen quencher). It is important to note that 
Parkhurst et al, (1968) has demonstrated that the second mechanism operates when a-
tocopherol is present together with other substance(s) which is/are capable of 
"regenerating" a-tocopherol from its radical form. It has been shown that glutathione 
and ascorbic acid can regenerate a-tocopherol from its tocopheroxyl radical in vivo 
and in vitro and thereby restores its antioxidant activity (Niki et al., 1987; Nijus et al., 
1991; Packer et al.’ 1979; Scarpa et al., 1984; Wefers et al., 1988b). The third 
mechanism by which many synergists work through "trace metal chelation". For 
example, a-tocopherol showed synergistic effects with phospholids because the latter 
mainly functions as a metal-chelator (Hamzawi et al., 1990). 
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4.2 Objectives 
The present experiment was to study whether Kudingcha phenylethanoid 
glycosides would maintain a-tocopherol level in human LDL, and acteoside, the 
major phenylethanoid glycoside in Kudingcha, would regenerate a-tocopherol from 
its free radical form in human L D L in vitro. 
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4.3 Materials and Methods 
4.3.1 Depletion of a-tocopherol in LDL 
Human L D L was isolated as previously described in chapter 3. The stock L D L 
fraction (5 mg proteinAnl) was dialyzed against 100 volumes of the degassed dialysis 
solution (pH = 7.4) containing 0.01 M sodium phosphate, 0.9% NaCl, 10 ^iM EDTA 
and 0.05% NaN^ in the dark for 24 hours. Oxidation of a-tocopherol in L D L was 
induced by 2,2'-azo-bis (2-amidinopropane) dihydrocholoride (AAPH), a peroxyl free 
radical initiator. The L D L (150 pig protein/ml) was incubated in sodium phosphate 
buffer (pH = 7.4, 10 mM) at 37 °C with constant stirring. The various amounts of the 
Kudingcha phenylethanoid glycosides were added before the addition of 1.0 m M 
AAPH. A n aliquot o f the incubation solution (1 ml) was recovered and chilled in ice. 
One ml of ethanol containing 0.5 mg of butylated hydroxyltolune as an antioxidant 
and 1.0 ^ig of tocopherol acetate as an internal standard were added and immediately 
extracted wi th 2 ml o f hexane. The hexane was evaporated under a gentle stream of 
nitrogen and the resulting extract was redissolved in 100 ^il o f ethanol and subjected 
to HPLC analysis for determination of a-tocopherol in LDL. 
4.3.2 Regeneration of a-tocopherol in LDL 
The stock L D L fraction (5 mg protein/ml) was dialyzed against 100 volumes of 
the degassed dialysis solution (pH = 7.4) containing 0.01 M sodium phosphate, 0.9% 
NaCl, 10 ^iM EDTA and 0.05% NaN3 in the dark for 24 hours. Oxidation of a -
tocopherol in L D L was induced by 1.0 m M AAPH. The L D L (150 ^ig proteinAnl) was 
incubated in sodium phosphate buffer (pH = 7.4，10 mM) at 37 °C wi th constant 
stirring. Acteoside was added at 5 minutes interval during the ongoing reaction. An 
63 
aliquot of the incubation solution (1 ml) was recovered and chilled in ice. One ml of 
ethanol containing 0.5 mg of butylated hydroxyltolune as an antioxidant and 1.0 [ig of 
tocopherol acetate as an internal standard were added and immediately extracted with 
2 ml of hexane. The hexane containing a-tocopherol was evaporated under a gentle 
stream of nitrogen. The residue was redissolved in 100 ^il of ethanol and subjected to 
HPLC analysis for the determination of a-tocopherol 
4.3.3 HPLC analysis of a-tocopherol in LDL 
a-Tocopherol in L D L was determined using a Shimadzu LC- lOAD HPLC 
(Tokyo, Japan) equipped with a ternary pump delivery system. In brief, 10 ^il o f the 
extract dissolved in ethanol was injected onto a C-18 column (Microsorb MV, 250 x 
4.6 mm, i.d., 5 ^im, Rainin, Woburn, M A ) via a rheodyne valve (20 ^il capacity, Cotati， 
CA). Methanol was used as an eluting solvent at a flow rate of 2 ml/min. a-
Tocopherol was monitored by using a diode array detector at either 200 nm or 280 nm 
and quantified according to the amount of a-tocopherol acetate standard added. 
4.3.4 Statistics 
Data are expressed as mean 士 standard deviation (SD). One way analysis of 
variance (ANOVA) and Student's "test were used where applicable for statistical 
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Figure 4.1 HPLC chromatogram of a-tocopherol analysis 
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4.4 Results 
4.4.1 Protective effects of Kudingcha phenylethanoid glycosides on a-
tocopherol depletion 
I t was previously shown that the rate of a-tocopherol depletion increased 
proportionally wi th increasing concentration of AAPH from 0.5 to 5 m M (Zhu et al., 
1999). A l l subsequent L D L oxidation experiments were, therefore, initiated using 1.0 
m M AAPH at 37 °C. When 1.0 mM AAPH was added in the L D L incubation mixture, 
there was a rapid consumption of L D L a-tocopherol. Complete depletion a-
tocopherol occurred within the first hour (Figure 4.2). Addition of 10 ^iM cis-
ligupurpuroside B, ^aw5-ligupurpuroside B and osmanthuside B to the incubation 
medium did not show any inhibitory effect on a-tocopherol consumption (Figure 4.2). 
The rate of a-tocopherol depletion in LDL mediated with cw-ligupurpuroside B, 
rraw5-ligupurpuroside B and osmanthuside B was similar to that ofthe control sample. 
When 10 ^iM acteoside, isoacteoside and ligupurpuroside A were added in the LDL 
incubation mixture, they demonstrated the protecting activity to a-tocopherol in LDL. 
The percentage of a-tocopherol in LDL remained unchanged for at least 4 hours. 
When 10 ^iM epicatechin gallate (ECG) was added, it could maintain 100% o f a -
tocopherol in L D L for at least 4 hours. It is known that ECG is a strong antioxidant 
present in green tea. The present data indicate that Kudingcha contains effective 
antioxidants at least as same as ECG. 
Acteoside, isoacteoside and ligupurpuroside A, isolated form Kudingcha 
exhibited a dose-dependent protecting activity to a-tocopherol in LDL. To be specific, 
the complete depletion of a-tocopherol in LDL was extended to 6 hours in the 
presence of 1 ^iM acteoside when compared with the control sample (Figure 4.3). For 
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Figure 4.2 Effect of Kudingcha phenylethanoid glycosides on depletion of 
a-tocopherol in human low-density lipoprotein OLDL). Data are expressed as means ± 
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Figure 4.4 Dose-dependent effect of ligupurpuroside A on depletion of a-tocopherol 
in human low-density lipoprotein (LDL). Data are expressed as means 土 SD of n=4 
samples. Means at the same time point with different letters (a-d) differ significantly 
(p<0.01) 
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the same period, only 20% depletion of a-tocopherol in L D L was observed when 
incubated in the presence of 5 ^iM. In comparison, a-tocopherol in L D L remained 
unchanged in the presence of 10 ^iM for at least 8 hours. Similar protective activity of 
a-tocopherol in L D L was also observed by both isoacteoside and ligupurpuroside A 
(Figures 4.3 & 4.4). Similar depletion pattern and percentage of the remaining oc-
tocopherol were found in the same concentration of isoacteoside and ligupurpuroside 
A under the same experimental conditions. 
4.4.2 Regeneration of a-tocopherol by acteoside 
To examine whether acteoside regenerates a-tocopherol from its free radical 
form, varying amounts of acteoside were added at 5 minutes after the a-tocopherol 
consumption reaction had been initiated. a-Tocopherol in L D L decreased to 50 % of 
its original amount at 10 minutes followed by a gradual recovery to 91 % at 1 hour 
when 5 ^iM of acteoside was added into the incubation medium. The similar time 
course ofregenerating a-tocopherol in LDL was also observed when 1 and 10 ^iM of 
acteoside were added 5 minutes after the reaction had been started (Figure 4.4). When 
1 ^iM of acteoside was added, a-tocopherol was regenerated up to 80 % at 1 hour. 
100% of a-tocopherol could be regenerated when 10 ^iM of acteoside was added into 
the incubation medium • 
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Figure 4.5 Regenerating effect of acteoside on regeneration on of a-tocopherol in 
human low-density lipoprotein (LDL). Acteoside was added at 5 minutes after the 
addition of AAPH [2,2'-azo-bis (2-amidinopropane) dihydrochloride]. Data are 
expressed as means 土 SD ofn=4 samples. Means at the same time point with different 
letters (a-d) differ significantly (p<0.01) 
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4.5 Discussions 
The present study of the Kudingcha phenylethanoid glycosides is particularly 
important in understanding the health effect of consuming Kudingcha. The present 
results clearly showed that acteoside, isoacteoside and ligupurpuroside A not only 
inhibits L D L oxidation as shown in previous chapter (Figures 3.2-3.4) but also 
prevents a-tocopherol from depletion in LDL in vitro (Figures 4.2-4.4). Two distinct 
effects of acteoside, isoacteoside and ligupurpuroside A on a-tocopherol were 
observed. First, acteoside, isoacteoside and ligupurpuroside A directly protected this 
lipophilic antioxidant from oxidation in a dose-dependent manner (Figures 4.2 & 4.3). 
This inhibitory effect could be accounted for by a direct interaction between these 
phenyletanoid glycosides and AAPH free radicals in the aqueous phase. This is 
because these phenylethanoid glycosides may be free-radical chain-breaking 
antioxidants. Second, acteoside, the major component in Kudingcha, could act as a 
reductant that could recycle a-tocopherol from its free-radical form. This repairing 
effect on a-tocopherol level in L D L was partially restored when acteoside was added 
during the depletion reaction (Figure 4.5). 
a-Tocopherol regenerating property is not unique to acteoside, isoacteoside and 
ligupurpuroside A. Ascorbic and glutathione (GSH) have been shown to be capable of 
regenerating a-tocopherol in a number of systems. It was found that protection 
against the loss of a-tocopherol could be provided either by NADH-cytochrome b5-
dependent enzymatic recycling or by a nonenzymatic regenerating pathway involving 
ascorbate and dihydrolipoic acid in human erythrocyte membrane (Constantinecu et 
“/., 1993). This repairing effect of ascorbate and dihydrolipoic acid on a-tocopherol 
was also extended to human (Kagan et al., 1992). The study by Chan et al (1990) has 
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shown that ascorbate and GSH could also regenerate a-tocopherol in human platelets. 
To my best knowledge, the present study was the first time to demonstrate that 
acteoside also processes a-tocopherol-repairing activity in human L D L under the 
present experimental conditions. It is known that a mixture containing both water-
soluble and fat-soluble antioxidants w i l l be more effective than a single quenching 
free radicals in both aqueous and lipid phases (Chen and Tappel, 1996). The anti-free-
radical function of a-tocopherol can be therefore augmented when any water-soluble 
antioxidant, particularly ascorbic and possibly acteoside, is present due to the 
regenerating activity of a-tocopherol. 
The major phenylethanoid glycosides demonstrated various protective effects on 
a-tocopherol in LDL. cz^-Ligupurpruoside B, /ra/7^-ligpurpuroside B and 
osmanthuside B were relatively ineffective in the protection of a-tocopherol from 
oxidation than acteoside, isoacteoside and ligupurpuroside A. These results were 
similar to the protection of human LDL from oxidation illustrated in the previous 
chapter. It remains unclear why acteoside, isoacteoside and ligupurpuroside A were 
more effective in the protection of human L D L from oxidation than cis-
ligupurpuroside B, trans-ligpurpurosidQ B and omanthuside B. Perhaps an additional 
hydroxyl group (Figure 2.6) present in each of phenol groups of acteoside, 
isoacteoside and ligupurpuroside A is responsible. Thus, acteoside, isoacteoside and 
ligupurpuroside A are more vulnerable to donate a hydrogen than c/^-ligupurpuroside 
B, ^aw5-ligupurpuroside B and osmanthuside B and have stronger protective effects 
against a-tocopherol oxidation. Due to the similar structures of acteoside, isoacteoside 
and ligupurpuroside A, they demonstrated a similar protective effect against a-
tocopherol oxidation. 
a-Tocopherol is the major lipid-soluble radical-trapping antioxidant in LDL 
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(Esterbauer et al., 1990). L D L begins to oxidize when the endogenous a-tocopherol is 
totally depleted (Kontush et al., 1996). Acteoside, isoacteoside and ligupurpuroside A 
have demonstrated the protective effect to the a-tocopherol oxidation in human LDL. 
One of the mechanisms is that acteoside, isoacteoside and ligupurpuroside A can 
"spare" or maintain the level of a-tocopherol in human LDL. 
The results obtained in this experiment, although not directly transferable to 
humans, may have some implications for individuals who drink Kudingcha. There 
have been extensive researches on green tea drinks but not many studies have been 
done on Kudingcha drinks. To my best understanding, there is limited information 
available as yet on the absorption, metabolism，and excretion of Kudingcha major 
phenylethanoid glycosides. More studies should be carried out to explore the effects 
ofKudingcha on a-tocopherol in vivo. 
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Chapter 5 
Relaxing effects of Kudingcha extract and 
purified acteoside in rat aortic rings 
5.1 Introduction 
Increased contractile tone generated by hypertensive vascular smooth muscle 
cells has been generally considered the physiological end point in the sequence of 
events that occurs in hypertension. More specifically, hypertension, defined as an 
elevated blood pressure, can develop when total peripheral vascular resistance is 
increased. Although a variety of mechanisms have been postulated for the causes and 
genesis of hypertension, there is clearly a convergence of pathways at the smooth 
muscle cells of the resistance vessels to elicit a directly related increase in contractility 
and blood pressure. 
I t is this end point in the hypertensive process that is affected by vasodilators. 
These agents do not act on the various putative regulatory systems that are believed to 
play important roles in control and/or modulation of vascular resistance. Instead, their 
action is directly on the vascular smooth muscle cell to interfere, in some manner, 
with the contractile response. The desired result is either a decrease in elevated 
contractile tone or prevention of an increased contractile response. Thus, vasodilators 
do not cure hypertension. The conditions that initiate events leading to vascular 
hypertension are not changed by vasodilators and, presumably, may persist or even 
progress. However, by either dilating or preventing constriction of resistance vessels, 
vasodilators wi l l decrease elevated blood pressure or block the onset of increased 
vascular tone and, in doing so, prevent the variety of deleterious physiological 
consequences ofovert maintained or intermittent hypertension. 
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The regulation of cytosolic calcium concentration in smooth muscle is 
characterized by numerous calcium permeant ion channels mediating calcium flux 
across the sarolemma and sarcoplasmic reticulum，and by a substantial diversity 
between tissues wi th regard to the extent that individual channels contribute to 
excitation-contraction coupling. The increase of the cytosolic calcium concentration 
w i l l lead to the contraction of the smooth muscle. 
5.1.1 Mechanisms of calcium mobilization 
5A.1.1 Voltage-dependent calcium channel 
There are six subtypes of voltage-dependent Ca〗+ channels: L- , N- , P-, Q-, R-， 
and T-type. In smooth muscle, only the L-type Ca〗+ channel is considered to be a 
major Ca^^influx pathway (Ganitkevich and Isenberg，1991; Hofmann and Klugbauer, 
1996; Kuriyama et al., 1995; Knot et al.’ 1996; Vogalis et al., 1991). This channel is 
activated by membrane depolarization and inhibited by Ca〗+ channel blockers. 
Agonists open this channel by depolarizing the cell membrane through activation of 
the nonselective cation channel (Pacaud and Bolton, 1991), inhibition of the K+ 
channel and/or activation o f the C1" channel (Ii j ima et al., 1991; Kremer et al., 1989; 
Miyoshi and Nakaya, 1991; Pacaud et al., 1991). Furthermore, agonists may open the 
L-type channels directly or indirectly through GTP-binding proteins in the absence of 
membrane depolarization (Kamishima et al., 1992; Nelson et al., 1988; Tomasic et al., 
1992; Worley etal, 1991;Welling etal, 1992a, b, 1993). 
High K+-induced depolarization induces a sustained increase in cystolic Ca】+， 
due to the opening of the voltage-dependent Ca〗+ channels, and a sustained 
contraction. This channel is inhibited by some agents, such as，verapamil, nifedipine 
and La3+. 
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5.1.2.2 Thromboxane A^ receptor-mediated calcium channel 
Although the agonist-induced influx of extracellular Ca〗+ via L-typed voltage-
dependent Ca2+ channels plays an important role in contraction of vascular smooth 
muscle, some evidence suggests that Ca】+ influx via channels other than L-typed may 
also mediate contraction. For example, blockers ofL- type Ca^^ channels only partially 
inhibited norepinephrine-induced contraction in rabbit ear artery (Casteels and 
Droogmans，1981). In addition, Morel and Godfraind (1991) suggested that Ca】+ 
influx via non-L-type Ca】+ channels may contribute to agoinst-induced contraction, 
because nisodipinem, an L-type Ca】+ channel blocker, only partially inhibited 
norepinephrine-induced ^^Cd^^ influx and the associated contraction in rat aorta. And 
it is believed that receptor-operated calcium channels, which open in response to 
receptor ligands, mediate this Ca^^ influx and the associated contraction. 
Thromboxane A】（TXA?) is a cyclooxygenase metabolite produced during the 
coronary artery disease. It possesses a high affinity for the T X A : receptor mediated 
Ca2+channel and produces the Ca^^ influx (Tosun et aL, 1997) and the associated 
contractile responses in rat aorta. 
5.1,1.3 Protein kinase C in signal transudation 
Protein kinase C (PKC) is a key enzyme involved in the regulation o f diverse 
cellular processes such as growth, differentiation, metabolism, secretion, and smooth 
muscle contraction (Nishizuka, 1992). In general, PKC transduces extracellular 
signals (e.g. growth factors, hormones, neurotransmitters) by phosphorylation of 
cellular target proteins on specific serine or threonine residues, ultimately producing a 
physiological response. 
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a - , p - , 5-，8- and ^-Isoenzymes o fPKC have been detected in vascular smooth 
muscles. The tumor-promoting phorbol esters induce slow, sustained contractions of 
vascular smooth muscle strips that were, at least in part, reversible upon washout of 
the phorbol esters (Danthuluri. and Deth., 1984; Morgrga. and Morgan., 1984; 
Rasmussen et al., 1984; Singer, and Baker.，1987). Related phorbol compounds that 
do not activate PKC failed to elicit a contractile response. In some cases, it has been 
shown that addition o f the active phorbol ester triggers a transient increase in 
sacroplasmic free Ca】+. In the presence of external Ca〗+, Khali l et al. (1992) found 
that contractions may be mediated by a - and 5—isoforms，whereas phorbol ester-
induced contractions in the absence of external Ca】+ may be mediated by s - and 
C -^ isoforms. 
5.1.3 Contractile proteins and regulation of contraction of vascular 
smooth muscle 
Contraction of vascular and other smooth muscles is regulated by the 
concentration of Ca〗+ in the vicinity of the contractile proteins and thus is similar to 
regulation of contraction of striated muscle, via a cross-bridge cycling - sliding 
filament mechanism. This mechanism is involved in both thin filament and thick 
filament in smooth muscle cells. 
The thin filament is composed mainly of the contractile protein, actin. G-actin 
monomers, which are single-chain globular proteins wi th a molecular weight of 
approximately 42,000 daltons, are arranged so that a two-stranded helical filament is 
formed (Figure 5.1). Tropomyosin，a rod-like dimeric protein wi th a molecular weight 
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Figure 5.1 Diagrammatic representation of the major contractile proteins ofvascular 
smooth muscle. The thin filament is comprised of actin, tropomyosin, and caldesmon， 
whereas the thick filament is comprised of the myosin light chains and myosin heavy 
chains. (Adapted from George B. et al., 1990) 
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of an approximately 70,000 daltons, is another major protein constituent of the 
smooth muscle thin filament. A third major protein of the thin filament is caldesmon, 
which is a dimer with a molecular weight of 120,000 to 150,000 daltons. The 
stoichiometric distribution of actin : tropomyosin : caldesmon is 1 : 7 : 28 (Smith et 
al., 1987). Caldesmon is capable ofbinding Ca^+and is phorphorylatable. 
The thick filament of smooth muscle is comprised entirely of the contractile 
protein, myosin (Figure 5.1). Myosin is a hexameric molecule consisting o f two high 
molecular weight subunits (heavy chain) (Figure 5.1) and four low molecular weight 
subunits (light chain). In native myosin, the overall configuration is that of an 
intertwined coiled tail region with two protruding "head" regions. These head regions 
project from the thick filament and contain the actin-binding regions. According to the 
sliding filament theory of muscle contraction, tension development and shortening 
occur as a result of actin-myosin interactions, causing thick and thin filaments to 
move past one another. Although smooth muscle lacks the well-ordered structure of 
the sarcomere that is present in striated muscle, careful ultrastructural and 
topographical analysis of the thin and thick filaments in smooth muscle reveals an 
organization that is consistent with a similar mechanism of contraction with dense 
bodies serving as the attachment sites for the thin and thick filaments (Small and 
Sobieszek 1980; Somlyo, 1980). The light-chain subunits of myosin are associated 
with the head region of the molecule. In smooth muscle, two pairs of light chains, 
with molecular weights ofapproximately 17,000 and 20,000 daltons, are present. The 
20,000-dalton light chain is of particular interest in that it can bind divalent cations 
and is capable ofbeing phosphorylated in a calcium-dependent manner. 
During excitation, intracellular levels of Ca〗+ increase and Ca】+ binds to 
calmodulin. Ca】+ binding to calmodulin leads to Ca^^-calmodulin-mediated activation 
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of a specific protein kinase myosin light-chain kinase (MLCK), which catalyzes the 
phosphorylation of serine -19 on the 20,000 dalton myosin light chain (MLC). When 
this M L C is phosphorylated, an increase in the rate of actin-myosin interactions 
occurs. It is possible to phosphorylate a second site (threonine) in smooth muscle by 
MLCK. Diphosphorylated MLC may be needed for further enhancement of actin-
myosin interactions (Persechini et al., 1986). 
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5.2 Objectives 
The present study examined the effects ofKudingcha (Ligustrumpurpurascens) 
extract and purified acteoside on the contractile response to various agonists in rat 
isolated aortic rings. 
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5.3 Materials and Methods 
5.3.1 Arterial ring preparation 
Male Sprague-Dawley rats weighing 〜250-300 g were killed by cervical 
dislocation and bled. The thoracic aorta was dissected out and surrounding connective 
tissues were carefully removed. The aorta from each rat was cut into three to four 
mm-wide ring segments. The tissues were suspended between two stainless wire 
hooks in a 10-ml organ bath. The upper wire was connected to a force-displacement 
transducer (Grass Instruments Co., USA) and the lower one fixed at the bottom of the 
organ bath. The organ chamber was fil led wi th Krebs solution wi th the following 
composition (in mM): 119 NaCl，4.7 KC1, 25 NaHCO3, 2.5 CaC^，1 MgC^，1.2 
KH.PO. , 11 D-glucose and 0.3 ascorbic acid. The bath solution was continuously 
Z^ 崎 
oxygenated wi th a mixture o f95% 0^ and 5% CO^ and maintained at 37。C to give a 
pH of approximately 7.4. The aorta rings were allowed to equilibrate under 1.0 g 
resting tension, which had been determined by length-tension relationship 
experiments. Changes in isometric tension were measured wi th force transducers and 
stored on a Maclab software (version 3.0) (Figure 5.2). The tissues were allowed to 
equilibrate for 90 minutes, during which time the bath solution was replaced wi th pre-
warmed and oxygenated Krebs solution every 15 minutes. The resting tension was 
readjusted to 1.0 g when necessary. Ninety minutes after being set up in organic bath, 
each ring was first contracted with a single concentration of phenylephrine (0.3 
iaM) and then relaxed by acetylcholine (1 ^ M ) to test its contractility and integrity of 
the endothelium, after which time the rings was rinsed wi th pre-warmed and 
oxygenated Krebs solution several times until the basal level o f tension was restored. 
The rings were then allowed to equilibrate further for 60 minutes. The resting tension 
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Figure 5.2 Diagrammatic illustration of isometric force measurement. An artery ring 
was mounted in an organ bath and changes in contractile force were detected by a 
Grass force transducer. 
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was readjusted when necessary. Each set of experiments was performed on the rings 
prepared from independent rat. 
5.3.2 Vascular action of Kudingcha extract and acteoside 
5.3,2.1 Relaxant responses of Kudingcha extract and acteoside on U466194nduced 
contraction 
In the first set of experiments, the contractile response of the rat thoracic aortic 
endothelium-intact rings was elicited by 20 nM U46619 following the equilibration 
period. In the endothelium-denuded arteries, the concentration of U46619 was 
lowered to 10 nM in order to match the magnitude of contraction in the endothelium-
intact rings. After the contractile response reached a steady level, either Kudingcha 
extract or acteoside was added cumulatively to induce a concentration-dependent 
response in both endothelium-intact and -denuded arteries. The effects of Kudingcha 
extract and acteoside on the basal tone were also tested. 
Some experiments, the rings were contracted with U46619 (0.3-100 nM) to 
obtain the first concentration-response curve. Once the maximal response to U46619 
was obtained, the rings were rinsed with pre-warm Krebs solution every 20 minutes 
until the tension returned to the basal level. The rings were then exposed to 
Kudingcha extract or acteoside of different concentrations for 30 minutes and another 
cumulative concentration-contraction curve to U46619 was repeated. 
5.3.2.2 Relaxant responses of Kudingcha extract and acteoside on high K^ and 
CaCl-induced contraction 
In the second group of experiments, the endotheHum-intact thoracic aorta was 
contracted with 35 m M extraceUular K+ to estabUsh a steady tension, Kudingcha 
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extract or acteoside was then applied cumulatively to the bath to cause 
concentration-dependent response. The high K+solution was prepared by substituting 
Na+ with an equimolar concentration ofK+. 
In another series of experiments, the artery rings were first stimulated with 0.3 
^iM pheylephrine in a Ca^^-free Krebs solution containing 1 m M Na^-EGTA to 
deplete intracellular Ca〗+ stores and then rinsed with Ca^^-free 35 m M K+ solution 
without EGTA several times until their resting tension was maintained or readjusted. 
The control cumulative concentration-response curve for CaCl^ (0.3-10 mM) was 
obtained in a Ca^^-free 35 m M K+ solution and the tissue was then washed first in 
Ca2+-free solution and then in Ca^^-free 35 m M K+ solution until the basal tension was 
restored. The second concentration-response curve for CaCl^ was repeated in the 
absence and presence of Kudingcha extract or acteoside (30 minutes contact time). 
The effect of the L-type voltage-sensitive Ca^^ channel inhibitor, nigedipine (10 nM), 
was also tested. 
5.3,2,3 Relaxant responses of Kudingcha extract and acteoside on protein kniase C-
mediated contraction 
In order to gain information whether Kudingcha extract or acteoside may also 
interfere wi th Ca^^-independent contractile mechanisms such as activation of protein 
kinase C in vascular smooth muscle cells, the effects of Kudingcha extract and 
acteoside were examined on phorbol 12,13 diacetate (PDA)-induced sustained 
increase of muscle tension. The artery rings were first incubated for 20 minutes in a 
Ca2+-free solution containing 1 mM Na^-EGTA and washed with the same solution 
twice before addition of 1 [ iM PDA, the protein kinase activator. Once a sustained 
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tension was achieved, Kudingcha extract or acteoside was applied cumulatively. 
5,3,2,4 Effect of acteoside on acetylcholine-inducedrelaxation 
Since acteoside induced a small increase in high K+-induced tone in 
endothelium-intact aortic rings, the effect of acteoside (0.125 and 0.250 mgAnl) was 
examined on the endothelium-dependent relaxation induced by acetylcholine. The 
endothelium-intact rings were equilibrated wi th acteoside (0.125 and 0.250 mg/ml) 
for 30 minutes and then contracted with 0.3 ^iM phenylephrine (Phe), acetylcholine (1 
n M - 3 ^iM) was added cumulatively to obtain the relaxation-response curve. 
5.3.3 Statistics 
To study the effect of drug on U46619- or CaCl^-induced contraction，values of 
EC and maximal increase in tension (E ) were compared in the absence and 
50 niax 
presence of Kudingcha extract or acteoside. Cumulative concentration-response 
curves were analyzed wi th a non-linear curve fitting by a logistic equation (Grafit, 
Erithacus Software Limited) and IC^^ was calculated as the drug concentration that 
caused a 50% relaxation. The results are mean 士 S.E.M. of n experiments. A 
probability level ofless than 0.05 was regarded statistically different. 
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5.4 Results 
5.4.1 Effects of Kudingcha extract and acteoside on U46619-induced 
contraction 
In the U46619-preconstricted rings, Kudingcha extract produced a concentration-
dependent relaxation to a similar extent in the absence and presence of the functional 
endothelium (IC^^: 0.144 土 0.006 mg/ml with endothelium vs 0.165 土 0.008 mg/ml 
without endothelium p>0.05, n=5-7, Figure 5.3). However, acteoside was more 
effective against U46619-induced contraction in endothelium-denuded rings than in 
endothelium-intact rings (IC50: 0.223 土 0.007 mg/ml n=7, with endothelium and 0.176 
土 0.003 mg/ml, n=7 without endothelium p < 0.05 Figures 5.3 & 5.4). In another 
series of experiments, U46619 contracted the rat isolated aortic rings with an EC50 of 
7.43 士 0.49 nM and a maximum increase in tension of 10.1 土 0.6 nM (n=6). 
Following a control curve for the U46619-induced contractile response, the 
endothelium-intact rings were incubated for 30 minutes with different doses of 
Kudingcha extract or acteoside and another concentration-response curve for U46619 
was again obtained. Figures 5.5, 5.6 and Table 5.1 showed that Kudingcha extract 
exerted an inhibitory effect on U46619-induced contraction. Similarly, acteoside also 
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Figure 5.4 The concentration-response curves for the relaxant effects of (a) 
Kudingcha extract and (b) acteoside in rat isolated aortic rings contracted by U46619 
(〇，n=7 with endothelium; •，n=5-7 without endothelium). The results are means 士 
S.E.M. o f n experiments. 
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Figure 5.5 Traces showing the contractile response ofU46619 in the absence (a), in 
the presence of 0.30 mg/ml Kudingcha extract (b) and 0.250 mg/ml acteoside (c) in 
the endothelium-intact rat aortic artery. The tissues were incubated with the drugs for 
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Figure 5.6 The concentration-response curves of contractile responses of 
endothelium-intact aortic rings to U46619 in the control (〇，n=6) and in the presence 
of(a) Kudingcha extract ( • , 0.10 mg/ml n=6; _ , 0.30 mg/ml n=6) or (b) acteoside ( • , 
0.125 mg/ml n=4; •，0.250 mg/ml n=4). Drug was incubated for 30 minutes before 
the second concentration-response curve was repeated. Data are expressed as 
percentages of the maximum contraction obtained in the first (control) concentration-
response curve. The results are means 士 S.E.M. o f n experiments. 
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Table 5.1 Effects ofKudingcha extract and acteoside on U46619- and CaCl2_induced 
aortic relaxation 
U46619 contraction CaCl: contraction 
Drug EC30 (nM) E _ (%) n EC50(nM) E _ (%) n 
Extract (mg/ml) 
0 7.4士0.5 103土4 6 0.34±0.03 100±5 6 
0.1 16.9±0.9a 9 7 ± 4 6 0.48土0.07 8 4 ± 1 1 4 
0.3 35.8 ±2.6a 5 3 ± 2 a 6 0.99±0.17a 55±11& 4 
Acteoside (mg/ml) 
0 7.4±0.5 103±4 6 0.34±0.03 100士5 6 
0.125 12.3±0.5a 8 9 ± 7 4 0.27±0.01 106±8 4 
0.250 23.9±1.8a 54±5& 4 0.19±0.02& 106±6 4 
The EC values and the maximal contraction (E ) induced by U46619 and CaCl in 
5 0 niax ^ 
the control and in the presence ofKudingcha extract or purified acteoside (30 minutes 
contract time). Statistical difference was indicated between the control and treatment 
groups (a P<0.05, two tailed Student's t-test). Values are means 土 S.E.M. of n 
experiments. 
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5.4.2 Effects of Kudingcha extract and acteoside on high K+-induced 
contraction 
U46619-induced sustained contraction is dependent on the presence of 
extracellular Ca】+ and Kudingcha extract or acteoside relaxed the U46619-
preconstriced aortic rings, hence raising the possibility that Kudingcha extract or 
acteoside may have a direct muscle relaxant effect by inhibiting Ca】+ influx. To test 
this, their effects on 35 mM K+-induced contraction was examined. Figure 5.7 showed 
that Kudingcha extract relaxed 35 mM K+-preconstricted rings (75.1 土 2.3o/o 
relaxation at 0.4 mg/ml, n=6), while acteoside induced forther contraction (19.5 士 
3.0% increase at 0.250 mgAnl，n=5). In aortic rings in the absence of extracellular 
Ca2+, and stimulated with 35 mM K+, CaCl2 induced a concentration-related increase 
of muscle tone. Figure 5.9 showed that Kudingcha extract caused a significant 
rightward shift inthe CaCl2 concentration-response curve (n=4, Table 5.1). In contrast, 
pretreatment with acteoside (0.125-0.250 mg/ml) enhanced the CaCl2-induced 
contractile response (n=4, Figures 5.8，5.9 and Table 5.1). In addition, a L-type 
voltage-gated Ca〗+ channel blocker, nifedipine at 10 nM, markedly suppressed the 
aortic contraction induced by CaCl2 (Figure 5.9), implying that the CaCl2-induced 
contraction in the high K+ solution was mainly mediated through Ca】+ influx via 
voltage-gated Ca^+ channels of depolarised cell membrane. The results were 
expressed as the ratio (%) of the second CaCl】 contraction over the first CaCl2 
contraction. The first contraction served as control and the second contraction in the 
presence ofdrug served as in index for the effect ofKudingcha extract or acteoside. 
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Figure 5.7 The representative traces showing a concentration-dependent relaxation 
induced by Kudingcha extract (a) and acteoside (b) in aortic artery ring pre-contracted 
with 35 m M K+ The effects of Kudingcha extract and acteoside on the contractile 
response to 35 m M K+ in endothelium-intact aortic rings (c). 
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Figure 5.8 Traces showing the contractile response of CaCl】 in the absence (a), in the 
presence of 0.30 mg/ml Kudingcha extract (b) and 0.250 mg/ml acteoside (c) in the 
endothelium-intact rat aortic artery. The tissues were incubated with the drugs in a 
Ca2+-free, 35Mm K+ solution for 30 minutes before the addition of CaCl】(0.01-10 
mM). Calibration bars apply to the traces. 
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Figure 5.9 Concentration-response curves for CaCl2-induced contraction of 35 mM 
K+-stimulated rat aortic rings in the control (〇，n=6) or in the presence of (a) 
Kudingcha extract ( • , 0.10 mg/ml n=4, _ , 0.30 mg/ml n=4,) or of (b) acteoside ( • , 
0.125 mg/ml n=4; _ , 0.250 mgAnl n=4 for acteoside; • , n=4 for 10 nM nifedipine). 
Drug was incubated for 30 minutes before the second concentration-response curve 
was repeated. Data are expressed as percentages of the maximum contraction obtained 
in the first (control) concentration-response curve. The results are means 士 S.E.M. of 
n experiments. 
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5.4.3 Effects of Kudingcha extract and acteoside on protein kinase C-
mediated contraction 
In order to test the possibility that Kudingcha extract and acteoside also relax the 
U46619-preconstricted aortic rings through Ca2+-independent intracellular pathways, 
phorbol 12,13 diaceate (PDA), a protein kinase C activator，was used to trigger 
sustained tension in the absence of extracellular Ca】+ (plus 1 m M Na^-EGTA). PDA 
at 1 ^iM produced a slowly-developing contraction and the maximal increase in 
muscle tension was 1.17 士 0.13 g (n=12). Figure 5.10 showed that the cumulative 
application ofKudingcha extract caused relaxation of the PDA-preconstricted rings in 
a concentration-dependent manner and the extract at 0.40 mg/ml induced 50.8 士 11% 
relaxation (n=8). However, acteoside only at 0.310 mg/ml started to reduce the PDA-
induced contraction (n=4, Figure 5.10). 
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Figure 5.10 The effects ofKudingcha extract (〇，n=8) and acteoside (參，n=4) on the 
contractile response to 1 ^iM phorbol 12,13-diacetate in Ca^^-free Krebs solution 
containing 1 m M Na2-EGTA. The results are means 士 S.E.M. of n experiments. 
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5.4.4 Effect of acteoside on acetylcholine-induced relaxation 
Acteoside exerted a contractile effect on 35 m M K+-preconstricted rings and its 
effect was greater in endothelium-intact rings (Figure 5.12), indicating the 
involvement of endothelium. Acetylcholine concentration dependently produced 
relaxation of phenylephrine-preconstricted aortic rings wi th an IC^^ of61.3 土 1.6 n M 
and 97.7 土 1.4o/o maximum relaxation (Figures 5.11 & 5.1¾. The relaxant effect of 
acetylcholine was absent upon removal of endothelium (n=4). Pretreatment with 
acteoside at 0.125 and 0.250 mg/ml for 30 minutes significantly attenuated the 
acetylcholine-induced relaxation (EC50 with E^x: 104.8 士 8.85 n M with 46.9 土 5.9%， 
n=4 and 54.2 土 14.2 n M with 26.9 土 10.8o/o, n=4 for 0.125 and 0.250 mgAnl acteoside 
respectively，p<0.05 compared with the control, Figures 5.11 & 5.12). 
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Figure 5.11 Traces showing the relaxant response to acetylcholine in the absence (a) 
and presence of 0.125 mg/ml acteoside (b) in the precontractile endothelium-intact 
aortic arteries induced by phenylephrine. The tissues were incubated with acteoside in 
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Figure 5.12 (a) The effect of acteoside on 35 m M K+-induced tone in the presence (〇， 
n=5) and absence (•，n=5) of endothelium, (b) The effect of acteoside on the 
acetylcholine-induced endothelium-dependent relaxation in rat aortic rings (〇，n=4 in 
control; •，n=4 in 0.125 mg/ml acteoside; _ , n=4 in 0.250 mg/ml acteoside). Drug 
was incubated for 30 minutes before the addition ofU46619. The results are means ± 
S.E.M. of n experiments. 
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5.5 Discussions 
An aqueous extract from the leaves of Eremophila alternifolia R. Br. 
(Myoporaceae) was found to increase heartbeat, cardiac contractility and coronary 
perfusion rate in the langendorff rat heart and verbascoside (syn: acteoside) is the 
major bioactive component of this extract (Pennacchio et al., 1995). These 
cardioactive effects may be partly mediated through increased release of prostacyclin 
(Pennacchio et al., 1996) that stimulated cyclic AMP production in the heart 
(Pennacchio etal., 1999). 
The ethanol extract from the leaves of Ligustrum japonicum which also contains 
glycosides was reported to enhance cardiac contractility and reduce blood pressure 
after venous administration to frog (Damirov and Trudov, 1960). However, there is no 
report in literature on the vascular action of Kudingcha extract and acteoside in the 
relaxing effect in rat aortic rings. 
The present results showed that Kudingcha extract relaxed concentration-
dependently the aortic rings preconstricted with U46619, a selective thromboxane A】 
receptor agonist and this effect was unrelated to the intact endothelium. It is generally 
thought that U46619-induced contractile response is mediated by extracellular Ca】+ 
influx (Tosun et a/.,1998) and protein kinase C is involved in enhancing Ca】+ entry via 
voltage-sensitive Ca�+ channel (Shearman et a/.,1989). U46619 was found to elevate 
PKC activity in arterial tissues (Kanashiro et al., 1998). The present study showed 
that Kudingcha extract significantly reduced the 35 mM K+-induced steady tension. 
• 2 + 
High K+ has been found to trigger smooth muscle contraction by promoting Ca 
influx through voltage sensitive Ca】+ channels that are readily activated by membrane 
depolarization. Therefore, extracellular Ca】+ influx is thought to be the main cause of 
high K+-induced contraction. Indeed, nifedipine, the L-type voltage-dependent Ca】+ 
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channel blocker, at 10 nM markedly reduced the high K+ response in the present study. 
Kudingcha extract also inhibited the CaCl2-induced contraction in the presence of 
extracellular 35 mM K+. These results clearly suggest that the extract contains 
components that could inhibit Ca】+ entry through voltage-sensitive Ca〗+ channels in 
aortic smooth muscle cells. 
The present study also showed that phorbol 12, 13-diacetate, an active phorbol 
that activates protein kinase C (PKC), induced slowly developing tension in Ca^^-free 
Krebs bath solution, indicating that PKC activation can interact with contractile 
filaments at the resting intracellular Ca】+ concentration (Huang, 1996). Kudingcha 
extract inhibited the phorbol ester-induced tone in a concentration-dependent manner. 
Kudingcha extract showed a decreasing in inhibiting contraction induced by three 
constrictors, U46619, PDA, and 35 mM K+, indicating that there may exist multiple 
active components that act through different intracellular pathways, leading to smooth 
muscle relaxation. 
Another aim of the present study was to identify the active components of 
Kudingcha extract. We isolated and purified acteoside, a major component that 
accounts for 2.05% ofthe total extract in weight and found that acteoside also reduced 
the U46619-induced contraction in a concentration-dependent fashion. However, the 
concentration range (0.006 - 0.312 mg/ml) used for acteoside was much higher than 
that (0.0002 - 0.0060 mg/ml) contained in 0.01 - 0.40 mg/ml Kudingcha extract, 
suggesting that acteoside is not the major ingredient responsible for the observed 
relaxation induced by the extract. Unlike Kudingcha extract, acteoside displayed 
higher potency in relaxing the preconstricted aortic rings without endothelium than 
those with endothelium. It is possible that acteoside could inhibit release or/and 
production of endothelium-derived relaxing factors such as nitric oxide. Indeed, 
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pretreatment of endothelium-intact rings with acteoside significantly attenuated the 
relaxant response to acetylcholine, a well known endothelium/nitric oxide-dependent 
dilator (Furchgorr and Zawadzki, 1980). This effect also explains the enhancing effect 
of acteoside on the CaCl2-induced contraction in 35mM K+-containing solution or on 
the 35 mM K+-induced contraction in endothelium-intact rings. 
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Chapter 6 
Effect of Kudingcha on lipid contents of 
hamsters and New Zealand Rabbits 
6.1 Introduction 
6.1.1 Factors related to CHD 
Accumulation of cholesterol in the arterial wal l is accompanied by the 
development of an atherosclerotic plaque (Brwon & Goldstein, 1986). It has been 
demonstrated that high serum cholesterol is a single, independent factor associated 
wi th coronary heart disease (CHD) (Rifkind & Lenfant，1986). However, it is found 
that high cholesterol level is not an absolute prerequisite for the development of 
atherosclerosis (Hamilton, 1997). L D L is a class oflipoproteins primarily responsible 
for initiating the sequence ofevents leading to advanced atherosclerosis。These events 
include the entering of monocytes into intima and the development of foam cells. 
However, recent evidence suggests that L D L itself may not be the prime culprit, but it 
needs to be oxidatively modified before being taken up by the monocyte-derived 
macrophages (Steinberg, 1997). 
I t is still an open tissue that high level of serum triaclglycerols (TG) is an 
independent risk factor for CHD (Hulley et al., 1980). Several studies have shown 
that serum TG is not associated with the risk of CHD independently (Holme et al., 
1985； Pocock et al‘’ 1989). For instance, TG does not appear to be significantly 
associated with CHD in a multivariate analysis (Holme et al., 1985; Rhoads et aL, 
1978). 
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6.1.2 Animal model 
New Zealand white rabbit is a common model for hypocholesterolmic study. 
Because rabbit is a non-rodent animal, cholesterol intake w i l l easily be accumulated in 
artery. The effects of drug on the cholesterol metabolism can be obviously observed. 
In recent years, it is an interest to use rabbit as an animal model for the study of 
atherogenesis (Barnes and Weinberg, 1999; Bloder et al.’ 1999; Haines et al., 1999; 
Lamb et al., 1999; Naka et al., 1998; Ponraj et al., 1999; Ramirez-Tortosa et al., 1999; 
Writ ing et al., 1999). It is because the cross section area of aorta of rabbit is great 
enough in scanning the atheroma formation. 
In addition to New Zealand white rabbit, Golden Syrian hamster {Mesocricetus 
Auratus) is also used widely as an experimental animal model in studying and 
estimating the efficacy of hypocholesterolemic agents in humans (Sugiyama et al., 
1995). The plasma cholesterol distribution in hamster is different from rat, in which 
most of i ts plasma cholesterol is in HDL, while the major plasma cholesterol carrier in 
hamster is in LDL, as in human (Nistor et al., 1987). It is found that about 50% 
plasma cholesterol in hamster occurs in the L D L fraction O^istor et al., 1987). 
Moreover, intrinsically low rates of hepatic cholesterol synthesis are found in both 
human and hamster. It is because increased hepatic influx of absorbed cholesterol 
could not be compensated in the species by down-regulation of cholesterol synthesis, 
but it may alter hepatic cholesterol excretion (Berr et al., 1993). Furthermore, there 
are similarities between hamster and human in their responses to different diets and 
drugs and in manner they handle biliary sterol secretion (Bocan & Guyton，1985; 
Spady & Dietschy, 1984). 
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6.2 Objectives 
Kudingcha is used as the folk medicine in southern China. It is claimed that it 
has the function oflosing weight (Ouyang et al., 1996a，1996b，1997). There has been 
no study to date examining i f Kudingcha decreases plasma cholesterol. In the present 
study, the effect of Kudingcha (Ligustrum purpurascens) on the lipid contents of 
hamsters and New Zealand rabbits was investigated. 
108 
6.3 Materials and Methods 
6.3.1 Rabbit 
New Zealand white rabbits were housed (1 rabbit per cage) in an animal room at 
25 °C with 12:12-h light-dark cycles. Diets were given daily. Food intake was 
measured weekly. Fluid intake was measured daily and body weight was recorded 
once a week. The New Zealand white rabbits were allowed access to food and fluid 
ad libitum. 
New Zealand White rabbits (n=24, 6 months) were divided into 3 groups. One 
group of 4 male rabbits were fed with normal chow diet and distilled water. Another 
group of 5 male and 5 female rabbits were fed with 1% cholesterol diet and distilled 
water. The last group of5 male and 5 female rabbits were fed wi th 1% cholesterol diet 
and 3% Kudingcha extract in distilled water. The control and high-cholesterol diets 
were purchased from Glen Forrest Stockfeeds (Western Australia, Australia). The 
basic ingredients of the diets per tone were as followed: oats, 50 kg; lupins, 205 kg; 
millmix, 250 kg; meat meal, 17 kg; lucerne, 320 kg; wheaten chaff, 160 kg; dicalcium 
phosphate, 5.7 kg; tallow, 5 kg; fish oil, 5 kg; vegetable oil, 38 kg; and vitamin and 
mineral premix, 4 kg. The high-cholesterol diet was prepared by adding 10 kg 
cholesterol to one tone of the control diet. The energy content and fatty acid 
compositions were listed in Tables 6.1 and 6.2. The pellet is in 5 mm diameter. To 
minimise storage changes, both the control and high-cholesterol diets were stored at 4 
°C. 
Blood was collected at 0，4, 8 and 12 weeks after overnight fasting via the lateral 
ear vein. After clotting, the blood was centrifuged at 1500 g for 10 minutes, and the 
serum was then collected. At the end of 12 weeks, all the rabbits were killed after 
overnight fasting under carbon dioxide anesthesia. The organs were removed, washed 
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Table 6.1 Composition of rabbit diets 
normal chow diet high-cholesterol diet 
Protein I ^ o T ^ 
Fat 7.5% 7.5% 
Crude Fibre 18% 18% 
Calcium 0.8% 0.8% 
Phosphorus 0.5% 0.5% 
Salt 0.1% 0.1% 
Cholesterol 0% 1% 
(adapted from Glen Forrest Stockfeeders) 
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Table 6.2 Fatty acid composition of the synthetic and normal rabbit diets 
Fatty acid Common name % of total fatty acids 
14:0 Myristic acid 0.70 士 0.11 
16:0 Palmitic acid 15.00土0.53 
16:1 n-7 Palmitoleic acid 0.48 士 0.14 
18:0 Stearic acid 4.91±0.53 
18:1 n-9 Oleic acid 26.66±1.49 
18:2 n-6 Linoleic acid 32.54士2.12 
18:3 n-3 a-Linolenic acid 4.26 士 1.15 
22:4 n-6 Docosatetraenoic acid 0.42 士 0.24 
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with saline, and stored at - 80°C. The thoracic aorta from the aortic bulb to the 
branching of the coeliac artery was then removed and checked for atheroma formation 
illustrated below. 
6.3.1.1 Measurement of atheroma formation 
The area of atheroma on the intimal surface of each aorta was calculated using a 
self organizing map neural network which characterized tissue according to selective 
colour staining. In each case, the fresh aorta was cleaned of adventitial tissue and 
washed in saline solution until clean. The vessels were then cut longitudinally and 
immersed in a solution of Sudan I I I (4% w/v in 70% alcohol) for 45 min. Sudan I I I is 
an organotrophic dye which is absorbed by the lipid. This is an established method of 
staining for atheroma detection. The image of each aorta was captured as 24 bit true 
colour using a Scanjet I I Cx desk scanner (Hewlett Packard, Hewlett Packard Asia 
Limited, Hong Kong) (Figure 6.1). A l l images were captured at a horizontal and 
vertical resolution of300 dots per inch (a pixel to pixel distance of 0.085 mm) using a 
brightness setting of 126 units and a contrast o f l l 2 units. Prior to image capture, all 
specimens were placed adventitial side down on white paper and then turned over 
with the intimal surface placed onto the glass surface of the scanner. 
Individual scanned images were processed using a pretrained self organizing 
map neural network (Figure 6.1). Individual pixels were classified within each image 
as either backgroup paper, unstained intimal surface tissue or atheromatous plaque. 
For each image the total surface area of atheromatous plaque as well as the percentage 
ofsurface ofplaque was determined. 
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Figure 6.1 Typical scanning pictures o f aorta after scanning Sudan I I I (a) and after 
the process ofusing a pretrained self organizing map neural network (b) 
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6.3.2 Hamster 
Male Golden Syrian hamsters were housed (3 hamsters per cage) in an animal 
room at 2 5 � C wi th 12:12-h light-dark cycles. Fresh semi-synthetic diets were given 
daily, and uneaten food was discarded. Food intake was measured daily and body 
weight was recorded twice a week. The hamsters were allowed access to food and 
f luid ad libitum. 
Hamsters (100-110g) were randomly divided into three groups (n = 12). They 
were fed a semi-synthetic diet, wi th supplementation of different extracts of 
Kudingcha. The method described by Sanders & Sandaradura (1992) was modified 
and used to prepare the semi-synthetic diet. For the control group, diet was prepared 
by mixing the powdered ingredients (casein, 200 g; lard, 200 g; starch, 418 g; sucrose, 
100 g; mineral mix, 40 g; vitamin mix, 20 g; DL-methionine，1 g; and cholesterol, 1 g) 
wi th 250 ml gelatine solution (40 g/L). The fatty acid competition of the semi-
synthetic diet was listed in Table 6.3. For the second group of hamsters, 0.94 % 
Kudingcha ethanol extract was mixed wi th the control diet before setting them in 
gelatine. Once the gelatine had set, the diet was cut into approximately 20g cubic 
portions and stored frozen (-20 °C). The third group of hamsters received 3 % 
Kudingcha water extract. The Kudingcha water extract was prepared by adding 15 g 
Kudingcha leaves into 250 ml offreshly boiled water. After 15 minutes, the infusion 
was filtered and the Kudingcha leaves were similarly extracted with an additional 250 
ml of freshly boiled water. The infiisions were combined to obtain 3.0% Kudingcha 
water extract. A t the end of 4 weeks, all the hamsters were killed after overnight 
fasting. Blood was collected via the abdominal aorta. After clotting, the blood was 
centrifuged at 1500g for 10 minutes and plasma was collected. Liver was removed, 
washed wi th saline, and stored at - 8 0 � C . 
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Table 6.3 Fatty acid composition of the semi-synthetic hamster diet 
Fatty acid Common name % of total fatty acids 
14:0 Myristic acid 2.37 土 0.04 
16:0 Palmitic acid 24.59±0.07 
16:1 n-7 Palmitoleic acid 2.50 土 0.03 
18:0 Stearic acid 15.25士0.09 
18:1 n-9 Oleic acid 40.58 ±0.16 
18:2 n-6 Linoleic acid 7.05 士 0.07 
18:3 n-3 a-Linolenic acid 0.50 士 0.01 
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6.3.3 Serum lipid determinations 
Serum total triacylglycerols (TG) and total cholesterol (TC) levels were 
determined wi th the use of enzymatic kits (Sigma Chemical, St. Louis, MO, USA), 
high-density lipoprotein cholesterol (HDL-C) was measured after precipitation of 
L D L and very low-density lipoprotein (VLDL) with phosphotungstic acid and 
magnesium chloride (Sigma). 
6.3.4 Determination ofhepatic cholesterol content 
Liver (300 mg) and 1 mg stigmastanol, as an internal standard, was homogenized 
in 15 ml chloroform-methanol (2:1, v/v) and 3 ml saline. The chloroform-methanol 
phase was removed and dried down under a gentle nitrogen steam. After 1 hour mild 
hydrolysis wi th 5 ml NaOH in 90% ethanol at 90 °C, 1 ml of water and 6 ml of 
cyclohexane were added for cholesterol extraction. The cyclohexane phase was 
evaporated to dryness under nitrogen and cholesterol was converted to its TMS-ether 
derivative by a commercial TMS-reagent (dry pyridine-hexamethyldisilazane-
trichlorosilane, 9:3:1, v/v/v, Sil-A regent, Sigma). After the incubation at 60 °C for 1 
hour, the mixture was dried under nitrogen. The TMS-ether derivative was dissolved 
in 600 pl of hexane, and after centrifugation, the hexane phase was transferred to a 
vial for gas-liquid chromatograph (GLC) analysis. The TMS-ether derivative was 
analyzed in a fused silica capillary column (SAC™-5, 30 m x 0.25 mm, i.d.; Supelco, 
Inc., Bellefonte，PA) in a Shimadzu GC-14B GLC equipped with a flame-ionization 
detector (Shimadzu). Column temperature was programmed at 285 °C and maintained 
for 20 minutes. Helium was used as carrier gas at a head pressure of 22 psi. A typical 
GLC chromatogram oftissue cholesterol is shown in Figure 6.2. 
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6.3.5 Statistics 
Data are expressed as mean 士 standard deviation (SD). The group means were 
statistically analyzed using one-way analysis of variance (ANOVA) and Student's t-
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Figure 6.2 A typical gas-liquid chromatographic profile of hepatic cholesterol and 
internal standard (stigmastanol) 
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6.4 Results 
6.4.1 Growth and Food intake 
The body weight and food intake o fNew Zealand white rabbit and hamsters are 
shown in Tables 6.4 and 6.5. No significant differences in body weight gain were 
observed among the control group and tested groups in both hamsters and rabbits 
studies. In the rabbit study, food intake in the normal chow diet group was 
significantly higher than the other two groups (p<0.05). In hamster study, there was 
no significant difference in the fluid intake among three groups. However, there is a 
significant higher food intake in the group given Kudingcha ethanol extract than the 
other two groups (p<0.05). 
6.4.2 Effect of Kudingcha supplementation on Serum TG, TC and 
HDL-C 
In the rabbit experiment, no differences were observed in serum TG and TC 
levels among the three groups before experiment. For the normal chow diet rabbits, 
serum TG (Figure 6.3) and TC (Figure 6.4) are maintained at the low level within 12 
weeks. After 4 weeks of feeding 1 % cholesterol diet, an increase in both serum TG 
and TC levels were observed in both the high-cholesterol control group and 
Kudingcha group. Both the TG and TC in Kudingcha group were slightly higher than 
control group at 4 weeks. At week 8 and 12, the serum TG and TC concentration of 
these two groups was similar. 
Serum HDL-C of normal chow, high cholesterol control and Kudingcha water 
extract was 20.59 士 5.53，8.31 士 1.37 and 8.99 土 3.88 mg/dl. I t was significantly 
higher for the normal chow group. But there were no significant difference between 
the high cholesterol control group and the Kudingcha group. 
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Table 6.4 Effect of Kudingcha water extract on body weight, food intake and fluid 
intake in New Zealand White rabbits 
Normal chow (4) ^ High cholesterol 
Control (10) Kudingcha (10) 
Initial body weight(kg) 3.10±0.67 3.51 ±0.38 3.19±0.40 
Final body weight(kg) 3.65±0.51 3.79±0.51 3.49±0.21 
Food intake (kg/wk) 1.04±0.06" 0.79±0.06b 0.77±0.07& 
Fluid intake (ml/d) 355.66 士 45.15 “ 257.02 土 40.73 ^ 337.38 士 42.27" 
^Figures in parentheses indicate the number ofNew Zealand white rabbits used. 
Data are expressed as means 土 SD. 
Means in the same row with superscript (a, b) differ significantly (p<0.05). 
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Table 6.5 Effects ofKudingcha water extract as drinking fluid and Kudingcha ethanol 
extract supplemented in diet on body weight, food intake and fluid intake in hamsters 
Control (12) ^ Kudingcha Kudingcha 
water extract (12) ethanol extract (12) 
Initial body weight (g) 112.23 土 5.20 112.16 士 2.61 113.84 士 7.33 
Final bodyweight (g) 128.74 士 7.92 132.81 士 5.53 135.83 士 9.20 
Food intake (g/d) 6.77±0.54" 7.07±0.64& 7.18 10.74^ 
Fluid intake (ml/d) 8.13 土 1.24 9.06 土 1.87 8.30 士 0.93 
^Figures in parentheses indicate the number ofhamsters used. 
Data are expressed as means 士 SD. 
Means in the same row with superscript (a, b) differ significantly (p<0.05). 
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Figure 6.3 Effect ofKudingcha water extract on serum triacylglycerols (TG) in New 
Zealand white rabbits. Data are expressed as means 土 SD of n = 4 for normal group, 
and n = 10 for the high cholesterol control and Kudingcha water extract groups. 
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Figure 6.4 Effect ofKudingcha water extract on serum total cholesterol (TC) in New 
Zealand white rabbits. Data are expressed as means 士 SD of n = 4 for normal group, 
and n = 10 for high cholesterol control and Kudingcha water extract groups. Means at 
the same time point with different superscripts (a, b) are significant at p< 0.01. 
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In the experiment of hamsters, the effect of different extracts of Kudingcha, i.e. 
the water extract as drinking f luid and the ethanol extract supplemented in diet, were 
examined. No significant differences were observed among the three groups in serum 
TG and TC (Table 6.8). Although the HDL-C in the control group was significantly 
higher than the group of ethanol extract (Table 6.8)，the ratio of non HDL-C to TC 
was not different statistically. 
6.4.3 Effect of Kudingcha supplementation on hepatic cholesterol 
contents 
In the rabbit experiment, the hepatic cholesterol was significantly lower in the 
normal chow diet group as compared with other two groups. However, the hepatic 
cholesterol concentration was similar among the high cholesterol control and the 
Kudingcha groups. The hepatic cholesterol concentration for the high cholesterol 
control group and Kudingcha group was 51.95 and 51.60 mg/g，respectively (Figure 
6.5). 
The effect of Kudingcha on the content of hepatic cholesterol of hamsters was 
shown in Figure 6.6. No differences were found among the three groups. The hepatic 
concentration of control group, water extract group and the ethanol extract group was 
35.88, 35.97 and 36.28 mg/g, respectively. 
6.4.4 Effect of Kudingcha supplementation on atheroma formation 
The effect of Kudingcha supplementation on atheroma formation in rabbits was 
shown in Figure 6.7. The percentage of atheroma formation is significantly low in the 
normal chow group. There is a slightly higher atheroma formation in Kudingcha 
feeding group, but it is not statistically significant. 
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Table 6.6 Effects ofKudingcha water extract as drinking fluid and Kudingcha ethanol 
extract supplemented in diet on serum lipids in hamsters 
Control (12) ^ Kudingcha Kudingcha 
water extract (12) ethanol extract (12) 
Serum TG (mg/dl) 210.31±63.41 225.28 ±43.59 233.44±64.89 
Serum TC (mg/dl) 131.96± 19.29 125.41 ±10.13 121.99±12.14 
SerumHDL-C (mg/dl) 73.96 士 8.14" 57.80 土 19.97& 53.97 ±17.77^ 
^Figures in parentheses indicate the number ofhamsters used. 
Data are expressed as means 土 o f n = 12. 
Means in the same row with superscript (a, b) differ significantly (p<0.01). 
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Figure 6.5 Effect of Kudingcha water extract as drinkng fluid on hepatic 
cholesterol in New Zealand white rabbits. Data are expressed as means 士 SD o f n 
= 4 for normal chow group, and n = 10 for the high cholesterol control and 
Kudingcha water extract groups. Means with the different superscript letters (a, b) 
are significant at p< 0.001. 
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Figure 6.6 Effect ofdifferent extracts ofKudingcha on hepatic cholesterol in 
hamsters. Data are expressed as means 士 SD o f n = 12 
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Figure 6.7 Effect ofKudingcha water extract as drinking fluid on atheroma formation 
in New Zealand white rabbits. Data are expressed as means 士 SD o f n 二 4 for normal 
chow group, and n 二 10 for high cholesterol control and Kudingcha water extract 
groups. Means with the different superscript letters (a, b) are significant at p< 0.001. 
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6.5 Discussions 
Previous studies suggest that two triterpenoid sapoins, cynarasaponin and 
ilexoside XLV I I I , from Ilex Kudingcha exhibited inhibitory effect on acylCoA 
cholesterol acyltransferase (ACAT) activity p^ishimura et al., 1999). ACAT functions 
mainly to esterify cholesterol and store it as cholesteryl ester, it may also play a key 
role in the intestinal absorption ofcholesterol (Hinder et al., 1983; Largis et al‘, 1989; 
Wrenn et al.’ 1995). There is evidence that majority of dietary cholesterol is esterified 
before it is assembled in chylomicron and secreted into the lymphatic system (Wrenn 
et al., 1995). Inhibition of intestinal esterification of cholesterol by ACAT has been 
shown to decrease cholesterol absorption (Vahouny & Kritchevsky，1981). To my 
best knowledge, there is still no scientific study demonstrating directly the effect of 
Kudingcha on the l ipid metabolism. This study is the first time to examine the effect 
ofKudingcha {Ligustrumpurpurascens) on serum TC and TG. 
In both the hamster and rabbit studies, there were no significant reduction in 
serum TG and TC in the groups fed Kudingcha extract supplemented either in 
drinking fluid or diet when compared with the control group. The results did not 
support the hypothesis that Kudingcha is hypolipidemic at least in hamsters and 
rabbits. Although HDL-C in the control hamsters was significant higher than the 
Kudingcha ethanol extract group in hamster study, the ratio of non-HDL-C to TC, 
which is commonly used as a risk factor in cardiovascular disease, was not different 
statistically. 
In the study of atheroma formation in the rabbit experiment. There was ahnost no 
atheroma formed in the normal chow group because no cholesterol was supplemented 
in the diet. The percentage of atheroma formation between the high cholesterol 
control and the Kudingcha groups were similar. I t demonstrated that Kudingcha could 
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not inhibit the atheroma formation in the aorta of the rabbit. Although Kudingcha had 
no effect in the inhibition of atheroma formation，oxidation o f L D L has been proposed 
to play an important role in development of atherosclerosis (Nielsen, 1999). The 
present result may imply that oxidatively modified L D L is not single factor 
contributing to formation of atheroma plaque. Its major phenylethanoid glycosides has 
demonstrated inhibitory effect on oxidation ofhuman L D L in in vitro study. 
Three basic mechanisms for cholesterol homeostasis are involved: (1) cholesterol 
synthesis is tightly regulated by the activity of hepatic 3 -hydoxy-3 -methylglutaryl 
coenzyme A reductase (HMG-CoA reductase); (2) cholesterol taken up from L D L is 
regulated by the number of L D L receptors in liver; (3) uptake of exogenous 
cholesterol is regulated predominantly by the intestinal ACAT. Kudingcha (Ligustrum 
purpurascens) may not inhibit the hepatic HMG-CoA reductase activity and the 
intestinal ACAT activity, because the present study did not prove that Kudingcha was 
hypolipidemic. In addition, Kudingcha could not reduce the concentration serum TG, 
this may be explained that Kudingcha could not inhibit the activity of liver fatty acid 
synthase. Although Kudingcha was not hypolipidemic, it was protective to human 
L D L from oxidation. I t also exhibited protection to a-tocopherol, one of the 




Kudingcha is widely used as a traditional beverage in southern China. It is used 
in traditional Chinese medicine as diuretic and for the treatment of sore throat, weight 
loss and hypertension. But there have been no scientific data to substantiate these 
biological effects. Kudingcha is a generic name which refers to different families and 
species. There are altogether 10 different species belonging 5 different families called 
“Kudingcha，，. In the present study, Ligustrum purpurascens f rom the family of 
Oleaceas was chosen. Five phenylethanoid glycosides were isolated and purified in 
Ligustrum purpurascens. They are acteoside, ligupurpuroside A, cw-liguprupuroside 
B，/raw^4igupurpuroside B and osmanthuside B. Isoacteoside was formed when 
acteoside was heated at 100 °C. 
Acteoside, isoacteoside and ligupurpuroside A demonstrated strong antioxidative 
a c t i v i t y in Cu2+-mediated oxidation of human low-density lipoprotein (LDL) in vitro 
while cw-ligupurpuroside B, ^raw^-ligupurpuroside B and osmanthuside B showed 
little or no protection to human LDL. The inhibitory effect of acteoside, isoacteoside 
and ligupurpuroside A was dose-dependent at concentrations ranging from 5 to 40 ^iM. 
The phenylethanoid glycosides extracted from Kudingcha did not show any chelating 
effect on Cu^+ ion to inhibit the initiation of free radicals. Many studies have reported 
that oxidative modification of L D L plays a crucial role in atherogenesis (Jiala & 
Devaraj, 1996; Steinberg, 1997; Nielsen, 1999). The protective effects ofKudingcha 
extract and five major phenylethanoid glycosides suggest that drinking Kudingcha 
may be beneficial against CHD. Further studies should be done on the absorption of 
phenylethanoid glycosides and their metabolism. 
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Acteoside, isoacteoside and ligupurpuroside A not only inhibited LDL oxidation 
but also prevented a-tocopherol from depletion in human LDL in vitro. Acteoside, 
isoacteoside and ligupurpuroside A showed dose-dependent protective effects on a-
tocopherol at concentrations ranging from 1 to 10 ^iM. cw-Ligupurpuroside B，trans-
ligupurpuroside B and osmanthuside B showed little or no inhibitory effect on a-
tocopherol consumption in human LDL. Acteoside demonstrated the activity of 
regenerating effects in a-tocopherol from its free radical form. a-Tocopherol is 
biologically and chemically the most active form of vitamin E (Burton et al., 1986). It 
is the major lipid-soluble radical-trapping antioxidant in LDL (Esterbauer et al., 1990). 
Protection to a-tocopherol from depletion implies that it can protect LDL from 
oxidation which is the major process in the development of atherogenesis. 
Kudingcha extract relaxed the U46619-preconstricted rat isolated aortic rings in 
a concentration-dependent manner. The extract also reduced the contraction induced 
by 35 m M K+ or by 1 ^iM phorbol 12,13-diacetate (PDA) in endothelium-intact rings. 
The extract (0.10 - 0.30 mg/ml) reduced the concentration-response to U46619 in 
normal Krebs solution or CaCl〗 in 35 mM K+-containing solution. This indicated that 
there may exist multiple active components that act through different intracellular 
pathways, leading to smooth muscle relaxation. Acteoside induced a concentration-
dependent relaxation of rings preconstricted by U46619 but it caused a forther 
increase in 35 mM K+-induced tone. Removal of the functional endothelium enhanced 
the relaxing effect of acteoside. Besides, pretreatment with acteoside inhibited 
endothelium/nitric oxide-mediated relaxation induced by acetylcholine. Acteoside 
(0.125-0.250 mg/ml) also enhanced the contractile response to CaCl2 in 35 mM K+, 
Ca2+-free Krebs solution. The concentration used for acteoside was much higher than 
that in Kudingcha extract, suggesting that acteoside is not the major ingredient 
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responsible for the observed relaxation induced by the extract. 
By using New Zealand white rabbit as an animal model, the effect ofKudingcha 
extract on l ipid contents of rabbit was examined. Rabbits were fed wi th 1% 
cholesterol synthetic diet wi th or without 3% Kudingcha as drinking fluid throughout 
12 weeks. There were no differences in serum TG, TC, HDL-C, hepatic cholesterol 
and atheroma formation in aorta. In hamster study, similar results were demonstrated 
when animals were fed wi th a high-fat and high-cholesterol semi-synthetic diet with 
or without 3% water extract of Kudingcha or 0.94% ethanol extract of Kudingcha. 
After 4 weeks, no differences were found in serum TG, TC，HDL-C/TC ratio and 
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